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The purpose of this study was to evaluate the prevalence of nonadherence and 
associated psychosocial factors (i.e., health beliefs, emotional distress and quality of life) 
in patients undergoing peritoneal dialysis (PD). Intentional (e.g., reasoned decision) and 
unintentional (e.g., forgetting) nonadherence were investigated as separate constructs and 
compared. It was a cross-sectional survey conducted with 144 PD patients. Nonadherence 
to all three main components of the therapeutic regimen, i.e., performing dialysis 
exchanges, taking medication as instructed and restricting dietary intake, was common, 
with dietary guidelines the most difficult to adhere to. Intentional nonadherence occurred 
more frequently than unintentional nonadherence for dialysis and diet; intentional and 
unintentional nonadherence to medication were equivalent. Nonadherence was strongly 
affected by psychosocial factors. More specifically, patient satisfaction was the most 
important predictor of intentional nonadherence to dialysis, whereas environment quality 
of life was the strongest predictor of unintentional nonadherence to dialysis. Self-efficacy 
was the strongest predictor of intentional and unintentional nonadherence to both 
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End Stage Renal Disease 
End stage renal disease (ESRD) is the final stage of chronic kidney disease 
(CKD), marked by a glomerular filtration rate (GFR) of less than 15 ml/min/1.73 m2. 
Patients with ESRD have kidneys failing to effectively remove wastes, keep appropriate 
levels of electrolytes (e.g., sodium, potassium, calcium, magnesium) and reabsorb 
glucose, blood proteins (e.g., albumin) and other small molecules (Kaazempur-Mofrad, 
Vacanti, Krebs, & Borenstein, 2004). Reported incident rates of ESRD varied from 13 in 
Bangladesh to 557 per million population in Morelos and reported prevalent rates of 
ESRD varied from 110 in Philippines to 2311 per million population in Taiwan in 2008 
(United States Renal Data System [USRDS], 2010). Diabetes mellitus is a major cause of 
ESRD, accounting for more than 40% of ESRD incident cases in most countries (USRDS, 
2010). Other important causes of ESRD include glomerulonephritis and high blood 
pressure. Symptoms common in ESRD patients include fatigue/tiredness, pruritus, 
constipation, anorexia, pain, sleep disturbance, anxiety, dyspnea, nausea, restless legs and 
depression (Murtagh, Addington-Hall, & Higginson, 2007). Transplant and dialysis are 
renal replacement therapy (RRT) choices for ESRD patients to partially restore their 
kidney functions and sustain life.  
Transplant  
Transplant is the most ideal form of treatment for ESRD patients. Prevalent rates 
of functioning grafts worldwide varied from 29 in Romania to 572 per million population 
in Norway in 2008 (USRDS, 2010). The corresponding rate in Singapore was 344.5 
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(Singapore Renal Registry [SRR], 2010). The 1- and 5-year survival rates for transplant 
patients in Singapore were 97.5% and 91.5% respectively (SRR, 2010). In transplant, a 
healthy kidney donated by a relative or others is placed in the body to take over the work 
of the old, dysfunctional kidney. Patients are required to continuously take 
immunosuppressants to prevent the body from rejecting the new kidney after 
transplantation. Apart from this, transplant patients live a relatively normal life, with 
much less fluid and dietary restrictions and clinical visits when compared to dialysis 
patients (Christensen & Ehlers, 2002).  
Despite the good clinical and psychological outcomes, kidney transplantation 
remains underutilized mainly due to a shortage of kidney donors. Only 23% of the treated 
ESRD patients worldwide were living with a functioning transplanted kidney at the end 
of 2004 (Grassmann, Gioberge, Moeller, & Brown, 2005). Furthermore, kidney 
transplantation is only an option for a select group of patients. Medical contraindications 
and high comorbidity burden limit the patient pool. Legislation may also preclude elderly 
patients, the fastest rising segment of the renal population (SRR, 2010), from transplant 
candidacy. In Singapore, patients over 60 are not eligible transplant candidates (Vathsala 
& Chow, 2009). National data indicates that most transplant kidneys (68%) are from 
deceased donors (SRR, 2010) and patients need to wait for a median of 9.44 years for 
deceased-donor renal transplants (Vathsala & Chow, 2009). Thus most ESRD patients 
need dialysis to sustain life.  
Hemodialysis  
Hemodialysis (HD) is the predominant dialysis modality used in most parts of the 
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Peritoneal Dialysis  
Peritoneal dialysis (PD) is a home-based renal therapy involving patients’ active 
participation. Patients or carers receive trainings about how to perform PD exchanges 
from PD nurses and are supposed to perform the procedures independently at home after 
the training period. Prevalent rates of PD worldwide varied from 2 in Bangladesh to 846 
in Hong Kong per million population in 2008 (USRDS, 2010). The corresponding rate in 
Singapore was 163.6 (SRR, 2010). The 1- and 5-year survival rates for PD in Singapore 
were 81.1% and 26.7% respectively (SRR, 2010).  
The basic PD procedure is demonstrated in Figure 2. PD uses patient’s 
peritoneum as a natural semipermeable membrane. While the diffusion process occurs 
outside the body of a HD patient, it occurs in the abdomen of a PD patient. A catheter 
(soft tube) is inserted into the abdomen of a PD patient and this operation makes the 
patient vulnerable to peritonitis. Dialysate flows into the peritoneal cavity through the 
catheter, stays there (patients are ambulatory during this period) absorbing wastes, toxins 
and excess water from the blood and then is drained out of the body together with the 
wastes. Then the infusion process begins again and the procedure repeats. The draining 
and infusion process is called an exchange, taking 30 to 60 minutes depending on the 
patient’s health status.  
These repeated exchanges can be performed either manually by patients 
(continuous ambulatory peritoneal dialysis, CAPD) or automatically using a mechanical 
devise over night (automated peritoneal dialysis, APD). As opposed to intermittent 
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PD vs. HD 
Clinical outcomes, namely mortality, morbidity and hospitalization, are 
comparable between PD and HD (Harris, Lamping, Brown, & Constantinovici, 2002; 
Keshaviah, Collins, Ma, Churchill, & Thorpe, 2002; Selgas et al., 2001). A study in 
Singapore found higher mortality in diabetic patients on PD than HD but not in non-
diabetic patients (Noshad, Sadreddini, Nezami, Salekzamani, & Ardalan, 2009). But the 
generalization of study is called into question as it only recruited 60 PD and 60 HD 
patients. There is good evidence indicating that PD enables better preservation of residual 
renal function (Moist et al., 2000; Oreopoulos, Ossareh, & Thodis, 2008) and is 
associated with less cognitive decline (Conde et al., 2010). 
A limiting factor of PD use is peritonitis (Bender, Bernardini, & Piraino, 2006). 
Peritonitis is probably the most important reason for PD technique failure and drop-out 
from PD programs, contributing to approximately16% death in PD patients (Davenport, 
2009; Kawaguchi et al., 2003; Li et al., 2010). There is a misconception that PD patients 
are more vulnerable to infections than HD patients due to peritonitis. In fact, the overall 
risks of infection are similar for PD and HD, although infection types are different 
(Aslam, Bernardini, Fried, Burr, & Piraino, 2006).  
PD and HD populations have distinct characteristics. PD population tend to be 
younger, married, healthier and more educated (Ahlmen, Carlsson, & Schonborg, 1993; 
Little, Irwin, Marshall, Rayner, & Smith, 2001; Marron et al., 2005; Ponz Clemente et al., 
2010; Stack, 2002). There is an increasing emphasis on expanding the penetration and 
utilization rate of PD. In Hong Kong, 79.4% patients are on CAPD (USRDS, 2010). 
Jalisco and Morelos are two places in Mexico where more than half of the dialysis 
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patients are on PD as well (USRDS, 2010). Since PD is less expensive, increasing the use 
of PD has significant effect on government budget. It has been estimated that if PD 
utilization increases to 40% in Singapore, savings to government will be around $ 25 
million per year (Walker, Chen, & Bhattacharyya, 2007). Although PD tends to be 
favored by the younger patients who are fully ambulatory and independent, it is important 
to recognize that currently there is a shift in recommending and placing less independent 
patients on PD regimes (Dimkovic & Oreopoulos, 2008). Offering PD to older patients 
can be supported by informal or formal carers who oversee dialysis procedures or by 
assisted PD schemes that involve daily visits by community nurses at patients’ home to 
initiate PD exchanges (Jassal & Watson, 2011).  
APD vs. CAPD 
 Research to date has focused predominantly on comparing medical endpoints 
between APD and CAPD, leaving the psychosocial outcomes poorly understood (Guney 
et al., 2010). Clinical studies cannot confirm a clear superiority of one modality over 
another, with most studies documenting equivalent outcomes in the two groups in terms 
of survival, technical failure, hospitalization, peritonitis, dialysis adequacy, clearance, 
hernias rates and the decline of residual renal function (Balasubramanian, McKitty, & 
Fan, 2011; Mehrotra, 2009; Mehrotra, Chiu, Kalantar-Zadeh, & Vonesh, 2009; Michels, 
Verduijn, Boeschoten, Dekker, & Krediet, 2009; Tang & Lai, 2007). 
APD may be more beneficial for certain groups, such as high transporters whose 
peritoneal membrane allows for rapid solute transport (Johnson et al., 2010). In addition, 
peritonitis risk is reduced in APD with Luer connections compared with CAPD with a 
disconnect system, as shown in two randomized controlled trials (Piraino & Sheth, 2010). 
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Another advantage of APD is its ability to reduce intra-abdominal pressure (Enoch, 
Aslam, & Piraino, 2002) which is frequently intolerable for some elderly. Known 
concerns regarding APD involve inadequate removal of sodium and poor hypertension 
control (Ortega et al., 2001; Rodriguez-Carmona, Perez-Fontan, Garca-Naveiro, 
Villaverde, & Peteiro, 2004). Individualization of APD based on patient characteristics 
may modify these risk factors (Brunkhorst, 2005). 
The percentage of APD in PD users is rising steadily in recent years in many parts 
of the world, like Canada, US, Singapore and Switzerland (Blake, 1999; Dell'Aquila, 
Berlingo, Pellanda, & Contestabile, 2009; Mehrotra, 2009) In Singapore, incident rate of 
PD patients choosing APD had increased from 3% in 1999 to 50.5% in 2008 (SRR, 2010). 
Patients are motivated to choose APD mainly due to the autonomy it provides instead of 
medical considerations (Mehrotra, 2009). APD is especially appealing to young and 
independent patients (Badve et al., 2008; Balasubramanian et al., 2011; Fine & Ho, 2002; 
Johnson et al., 2010). A main factor limiting APD use is the high cost associated with the 
machine. APD on average costs 20% more than CAPD (Dell'Aquila et al., 2009). 
Since APD is performed at night and less onerous, it is especially favorable for 
two groups of patients. The first group includes students and employers whose day time 
activities demand minimum disruptions (Dell'Aquila et al., 2009; Liakopoulos & 
Dombros, 2009). With the use of APD, patients do not need to interrupt their study or 
work several times a day to perform exchanges. APD also allows patients to avoid the 
embarrassing experience of performing exchanges in front of peers and thus is more 
appealing to patients.      
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The second group of patients who can gain great benefits from APD includes 
those who are highly dependent on others for their treatment, such as children and the 
elderly (Dell'Aquila et al., 2009; Liakopoulos & Dombros, 2009). Since only two 
connections are required for APD each day (vs. multiple connections in CAPD), it is 
easier for employed carers to perform these exchanges without major life disruptions. For 
elderly patients without good social support but still want to receive treatment at home, it 
is less expensive for APD patients to hire nurses to visit their house since APD requires 
fewer visits. Elderly patients on APD in nursing homes have more time to take part in 
day time activities and this greatly facilitates their rehabilitations (Dimkovic & 
Oreopoulos, 2008).  
Health Beliefs 
Past studies on patients’ health behaviors tend to depict patients as passive 
recipients of medical advice which is given to patients’ best interest (Donovan, 1995). 
Doctors feel frustrated about patients’ inability to stick to treatment plans which give rise 
to various adverse outcomes such as elevated hospitalization, morbidity and mortality 
(Vermeire, Hearnshaw, Van Royen, & Denekens, 2001). These disappointing outcomes 
motivate researchers to reexamine patients’ involvement in their therapy decisions and to 
take into consideration patients’ beliefs. Different models have been proposed to explain 
how patients’ beliefs affect their health decisions, such as the Health Belief Model (HBM) 
(Rosenstock, 1974), Theory of Planned Behaviour (TPB) (Ajzen & Fishbein, 1980), 
Common Sense Model (CSM) (Leventhal, Diefenbach, & Leventhal, 1992) and 
Medication Adherence Model (MAM) (Johnson, 2002). This study focused on two 
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models that receive significant research attention, namely Horne and Weinman’s (1999) 
necessity-concerns model and Bandura’s (1977) self-efficacy theory. 
Beliefs About Medicines 
Horne and Weinman (1999) proposed a necessity-concerns model to understand 
medication-taking behaviors among patients with chronic illnesses. The basic idea is that 
patients do not follow doctors’ advice without questioning, but perform elaborate 
calculations based on their beliefs about medicines. Main considerations include 
perceived usefulness/necessity of the prescribed medication and perceived disruptive 
effects/injuries caused by the medication. Patients are inclined to take their prescribed 
medication when the perceived necessity exceeds perceived concerns. Otherwise patients 
may adjust or skip medication to suit their needs. Necessity or concern beliefs can also 
work independently. For instance, if patients experience dangerous drug interactions as a 
result of taking their prescribed medication, they tend to adjust medication doses no 
matter how important they perceive the medication to be.  
Self-efficacy 
Self-efficacy is a key concept in Bandura’s social learning theory and is defined 
as “people’s beliefs in their capabilities to exercise control over their own level of 
functioning and over events that affect their lives” (Bandura, 1991, p. 257). The effect of 
self-efficacy in determining health behaviors is well-established in literature and this 
theory has been successfully applied in different settings such as smoking relapse 
prevention, pain management, weight control and rehabilitation from myocardial 
infarction (O'Leary, 1985). Dialysis patients experience various stressors caused by their 
disease and treatment. The top five stressors among dialysis patients are limitation of 
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physical activity, decrease in social life, uncertainty about the future, fatigue and muscle 
cramps (Lok, 1996). Patients’ with high self-efficacy are very likely to face these 
stressors directly, actively search for effective ways to minimize the influence of these 
stressors, set high goals for their behaviors to maintain health and remain resilient when 
confronted with physiological or social barriers (Bandura, 1977).  
Emotional Distress 
Emotional distress has received considerable attention in dialysis patients. 
Patients on dialysis have been reported to spend about six hours of their day (not 
including sleeping hours) in negative affective states (Song et al., 2011). A lot of factors, 
such as the intrusive nature of renal treatment (Griva, Davenport, Harrison, & Newman, 
2010), high burden of symptoms (Murtagh et al., 2007), impaired daily functioning 
(Cook & Jassal, 2008) and severe sleep problems (Guney et al., 2010) may give rise to 
high emotional distress in this group. Emotional distress can be further worsened by 
patients’ reluctance to get evaluation and treatment for it (Wuerth, Finkelstein, & 
Finkelstein, 2005), which may be especially pronounced in Singapore where there is a 
high level of stigma attached to mental illness (Lai, Hong, & Chee, 2001)   
Depression 
Typical major depression symptoms include “depressed mood, anhedonia, 
appetite or weight change, sleep disturbance, fatigue, psychomotor disturbance, feelings 
of worthlessness or guilt, impaired concentration and suicidal thoughts” (Koenig, George, 
Peterson, & Pieper, 1997, p. 1378). The golden standard for diagnosis of clinical 
depression is the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
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(DSM-IV) criteria. The Beck Depression Inventory (BDI) and Hospital Anxiety and 
Depression Scale (HADS) are the most widely used self-administered questionnaires for 
screening depression. Around 80% of patients classified as depressed based on BDI or 
HADS meet DSM-IV criteria (Atalay et al., 2010; Herrero et al., 2003; Wuerth et al., 
2005).  
Depression is the most common psychiatric disorder seen in dialysis patients 
(Ibrahim & El Salamony, 2008). The prevalence of major depression in patients on renal 
replacement therapy has been estimated to be from 20% to 30%, considerably higher than 
general populations (Atalay et al., 2010; Fukunishi et al., 2002). Since many symptoms of 
depression, such as appetite loss, fatigue and impaired concentration, may be renal 
disease manifestations, physicians may overlook the presence of depression among 
dialysis patients. 
Age, gender, smoking, comorbidities, serum IL-6, albumin, perceived illness 
effects and social support are useful in predicting depression (Hung et al., 2011; Kimmel 
et al., 1995; Osthus et al., 2010; Patel, Shah, Peterson, & Kimmel, 2002). Depression is 
associated with various adverse outcomes such as death, hospitalization and peritonitis 
(Diefenthaeler, Wagner, Poli-de-Figueiredo, Zimmermann, & Saitovitch, 2008; Hedayati 
et al., 2008; Troidle et al., 2003). For instance, it has been recognized that patients who 
scored 16 or higher on BDI had a 2.7-fold increased risk of mortality than those who 
scored lower on BDI (Chilcot, Davenport, Wellsted, Firth, & Farrington, 2011). It is 
unclear why depression is associated with poor outcomes, probably through impairing 
immune functioning, nutritional status and self-care abilities (Kimmel, Weihs, & 
Peterson, 1993). In addition, depressed patients are more likely to have poor sleep quality 
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(Guney et al., 2008) and sexual dysfunction (Lew-Starowicz & Gellert, 2009). 
Depression may also affect patients’ intention to withdraw from dialysis treatment 
(Christensen & Ehlers, 2002).  
Anxiety 
Anxiety is characterized by feelings of uncertainty, tension, helplessness, 
inadequacy, self-consciousness, concentration difficulties, feeling flushed, perspiring, 
damp hands, irregular breathing, racing heartbeat, and dry mouth (Endler, Parker, Bagby, 
& Cox, 1991). In contrast to the prosperity of studies on depression, anxiety in dialysis 
patients receives little attention, even though anxiety is also associated with poor 
outcomes such as lowered quality of life and increased likelihood of sexual dysfunction 
(Sayin, Mutluay, & Sindel, 2007; Steele et al., 1996; Vasilieva, 2006; Vazquez et al., 
2005). Conventional measures of anxiety include the Hospital Anxiety and Depression 
Scale (HADS) and the State-Trait Anxiety Inventory (Spielberger, 1985). The prevalence 
of anxiety was reported to be 18.6% in a recent study involving 97 adult HD and PD 
patients (Partridge & Robertson, 2011). Around one third of the HD patients were 
diagnosed with anxiety in the study of Taskapan et al. (2005). Few studies investigated 
the prevalence of anxiety in PD patients. A study in Singapore reported 13% depression 
and 50% anxiety in 30 CAPD patients (Lye, Chan, Leong, & van der Straaten, 1997).    
Loneliness 
Loneliness is defined as "to the extent that a person's network of social 
relationships is smaller or less satisfying than the person desires" (Peplau & Perlman, 
1979, p. 101). Perceptions of loneliness have rarely been recorded in dialysis patients, 
although it is reasonable to expect its high prevalence in this group, since dialysis patients 
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tend to have decreased social life and frequently face family problems and marriage 
malaises due to dialysis (Lok, 1996; Rapisarda et al., 2006). One phenomenological study 
identified loneliness as an important theme in patients’ experience with dialysis (Herlin & 
Wann-Hansson, 2010). Another study assessed loneliness among CAPD patients together 
with their carers and detected low level of loneliness in both groups (Asti, Kara, Ipek, & 
Erci, 2006). But this study used a relatively young patient sample (mean age around 45) 
and it may not be appropriate to generalize findings in this sample to the elderly patients 
who tend to have decreased economic and social resources (Buemi et al., 2008). 
Emotional Distress on APD vs. CAPD  
It is unclearly whether APD offers patients better psychological adjustment than 
CAPD, since only three studies with small sample sizes compared emotional outcomes in 
APD and CAPD patients and reported mixed results. One study reported equivalent 
depression rates in the two groups (Guney et al., 2010). Another study reported lower rate 
of depression in APD than CAPD patients (Griva et al., 2010). Similarly, de Wit, Merkus, 
Krediet and de Charro (2001) reported that APD patients were less depressed and anxious 
than CAPD patients. 
Quality of Life 
Quality of life is defined by the World Health Organization (WHO) as 
“individuals’ perception of their position in life in the context of the culture and the value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns” (Harper & Power, 1998, p. 551).  
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Quality of life measures can be divided into generic and disease-specific. Generic 
instruments measure concepts that are relevant to everyone’s well-being (e.g., life 
satisfaction), can be applied in different populations and allow comparisons across 
different groups (Patrick & Deyo, 1989). Disease specific measures are used only in 
limited populations, but are more sensitive in detecting small quality of life changes 
associated with specific conditions (e.g., severity of disease) (Valderrabano, Jofre, & 
Lopez-Gomez, 2001). The 36-item Short-Form Health Survey (SF-36), EuroQOL 5 
Dimension (EQ-5D), and World Health Organization Quality of Life Instrument, Short 
Form (WHOQOL-BREF) are the top three used generic quality of life measures, whereas 
the Kidney Disease Quality of Life instrument (KDQOL) and its shortened versions 
(KDQOL-SF, KDQOL-36) are the most commonly used measures for assessing disease 
specific quality of life in ESRD patients (Glover, Banks, Carson, Martin, & Duffy, 2011). 
The current study measured both generic and disease specific quality of life, as 
recommended in literature (Valderrabano et al., 2001).  
Quality of life impairment is predominant in dialysis patients when compared 
with healthy individuals (Maglakelidze et al., 2011; Osthus et al., 2010; Sayin et al., 
2007) , especially in the physical health domain (Bohlke et al., 2008; Brown et al., 2010; 
de Wit et al., 2001). Psychological factors, such as health beliefs and social 
support/deprivation, have been found to be important in predicting quality of life 
(Bakewell, Higgins, & Edmunds, 2002; Theofilou, 2011; Wight et al., 1998). Non-
psychological factors, such as age, gender, hospitalization, number of comorbid diseases, 
primary kidney disease, nutritional status and dialysis adequacy may also influence 
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quality of life (de Wit et al., 2001; Fructuoso, Castro, Oliveira, Prata, & Morgado, 2011; 
Senol, Sipahioglu, Ozturk, Argun, & Utas, 2010).   
The importance of quality of life is increasingly appreciated, not only because it is 
inversely correlated with hazards of hospitalization and mortality (DeOreo, 1997; 
Valderrabano et al., 2001), but also because it evaluates the effectiveness of treatment 
based on patients’ subjective feelings (Fructuoso et al., 2011). Dialysis patients are 
willing to trade less living time for better quality of life (Jhamb et al., 2011; Tsevat et al., 
1998), corresponding to Socrates’ adage that “The really important thing is not to live, 
but to live well”. Nephrologists also place more weight on quality of life than mortality 
and morbidity in recommending dialysis modalities (Mendelssohn, Mullaney, Jung, 
Blake, & Mehta, 2001). Various efforts have been initiated to improve patients’ quality of 
life, such as adjusting dialysis prescription, controlling comorbidities, treating anemia 
and alleviating depression (Ross, Hollen, & Fitzgerald, 2006).  
Quality of Life on APD vs. CAPD  
Although APD is expected to offer patients better quality of life due to its less 
onerous nature (Balasubramanian et al., 2011), this hypothesis is not well-supported in 
literature. Five studies compared quality of life outcomes between APD and CAPD 
patients, with four of them suggesting equivalent quality of life between the two groups 
based on SF- 36 scores (Balasubramanian et al., 2011; Bro et al., 1999; de Wit et al., 
2001; Guney et al., 2010) and one suggesting worse physical but better mental quality of 
life in APD patients (Diaz-Buxo, Lowrie, Lew, Zhang, & Lazarus, 2000). The last study 
(Diaz-Buxo et al., 2000) did not control for critical covariates (e.g., comorbidity, time on 
dialysis) and thus its results should be viewed with caution. A recent longitudinal study 
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examined quality of life in 119 APD and 105 CAPD patients with SF-36 and reported 
worse baseline quality of life in CAPD patients, but no differences were found after a 
year (Balasubramanian et al., 2011). Thus it is quite possible that PD modality per se is 
not a significant predictor of quality of life after patients adapt to it. 
Nonadherence 
Definition and Measurement of Nonadherence 
Any deviation from doctor’s treatment instructions was viewed as nonadherence 
in this study. In contrast to abundance of research on quality of life and emotional 
adjustment, there has been little focus on treatment nonadherence. Nonadherence to 
treatment regime is a key contributor to poor survival in patients treated with dialysis, 
probably in the same order of importance as medical indicators (Bander & Walters, 1998). 
Dialysis regimen is extremely complicated and time-consuming, involving regular 
clinical visits, attending dialysis sessions, taking a variety of medications, limiting water 
intake and paying great attention to food choices. As treatment complexity has been cited 
as the most important reason affecting patients’ nonadherence (Donovan, 1995), it is not 
unexpected that it is easy for dialysis patients to be nonadherent.  
Nonadherence studies in dialysis patients are greatly hindered by a lack of 
consistent standards for measuring nonadherence. Common measures of nonadherence 
include: (a) report from patients or medical staff, (b) biological and biochemical markers, 
(c) electronic monitoring and (d) checking medication refill status and inspection of 
dialysate delivery records. Each method has its own drawbacks. The most widely used 
method is self-report, a cost-effective way of measuring nonadherence (George, 
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Mackinnon, Kong, & Stewart, 2006), though there are doubts about the accuracy of self-
report (Horne & Weinman, 1999; Vlaminck, Maes, Jacobs, Reyntjens, & Evers, 2001). 
For instance, Haynes et al. (1980) reported that patients underestimated their 
nonadherence by 17% in self-reports when compared with pill count. Common biological 
and biochemical markers used to measure nonadherence include interdialytic weight, 
phosphorus, potassium and albumin levels (Karamanidou, Clatworthy, Weinman, & 
Horne, 2008; Kugler, Maeding, & Russell, 2011). The validity of using biochemical 
markers to indicate nonadherence is challenged by using arbitrary, instead of theory 
supported, cut-off values to divide patients into adherence and nonadherence groups and 
by factors irrelevant with nonadherence such as residual renal function, dialysis 
prescriptions, disease conditions and demographic characteristics (Denhaerynck et al., 
2007). Electronic devices such as the Medication Event Monitoring System (MEMS, 
Aardex, Switzerland) and the Home-Choice Pro card (Baxter Healthcare Corporation, 
Deerfield, Illinois, USA) are capable of providing reliable measures of nonadherence 
(Chua & Warady, 2011; Sevick et al., 1999), but the associated high costs limit their wide 
application. Medication refill rates (Gincherman, Moloney, McKee, & Coyne, 2010) and 
dialysate delivery records (Fine, 1997) cannot reveal whether patients actually utilize the 
medication or dialysate (e.g., patients may give the medication or dialysate to others) or 
whether patients use them correctly. The current study used the combination of self-
report (used in a non-threatening way) and biochemical markers (i.e., serum potassium, 
phosphate and albumin levels) to detect nonadherence and this design has been suggested 




Another key problem in past studies is treating nonadherence as an 
unidimensional concept, reflected by using a composite score to indicate overall 
nonadherence (Lin & Liang, 1997; Pakpour et al., 2010; Sayin et al., 2007; Vives et al., 
1999). However, patients do not perceive different aspects of the therapeutic regimen 
(e.g., dialysis, medication, diet, fluid) as equally important and have differing levels of 
difficulty in managing separate treatment components (Smith et al., 2010; Stack et al., 
2010). In studies measuring nonadherence to several components of the therapeutic 
regimen simultaneously, nonadherence rates were found to be different and affected by 
different factors (Karamanidou, Clatworthy, et al., 2008; Sensky, Leger, & Gilmour, 
1996). Therefore, it is more reasonable to assess nonadherence to different aspects of the 
therapeutic regimen as separate constructs. Studies reporting nonadherence rates to three 
main components of the therapeutic regimen (i.e., dialysis, medication and diet) among 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Nonadherence to Dialysis Procedures  
It is life-threatening if dialysis patients fail to perform dialysis exchanges as 
prescribed, since wastes, toxins and excess water may accumulate in the body and disturb 
its hemodynamic status. Despite its importance, nonadherence to dialysis prescriptions is 
a common problem. Reported rates of nonadherence to dialysis prescriptions in PD 
varied from 4% to 53% (Amici et al., 1996; Bernardini, Nagy, & Piraino, 2000; 
Bernardini & Piraino, 1997, 1998; Chua & Warady, 2011; Figueiredo, Santos, & 
Creutzberg, 2005; Fine, 1997; Kutner, Zhang, McClellan, & Cole, 2002; Lam, Twinn, & 
Chan, 2010; Neri, Viglino, Cappelletti, Gandolfo, & Barbieri, 2002; Nolph et al., 1995; 
Russo et al., 2006; Warren & Brandes, 1994). The corresponding rates in HD varied from 
0% to 32% (Bleyer et al., 1999; Block, Hulbert-Shearon, Levin, & Port, 1998; DeOreo, 
1997; Hecking et al., 2004; Kutner et al., 2002; Leggat et al., 1998; Sherman, Cody, 
Matera, Rogers, & Solanchick, 1994; Taskapan et al., 2005).  
Factors associated with nonadherence to dialysis prescriptions include smoking, 
younger age and ethnicity with blacks reporting more nonadherence than whites (Kimmel 
et al., 1995; Kutner et al., 2002; Leggat et al., 1998; Unruh, Evans, Fink, Powe, & Meyer, 
2005). Perceived negative effects of treatment on daily life and less control perception 
over future health were identified as predictors of shortening behaviors in one study 
(Kutner et al., 2002). Nonadherence to dialysis has been found to be associated with 
higher mortality and lower likelihood of kidney transplantation in HD (Unruh et al., 
2005). Data on PD patients showed that nonadherence to dialysis is associated with 
technique failure, inadequate dialysis, increased peritonitis rates and hospitalizations 
(Bernardini et al., 2000; Bernardini & Piraino, 1998).  
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Nonadherence to Medication 
In addition to performing exchanges regularly, dialysis patients are expected to 
take multiple tablets to control their phosphate levels (dialysis procedure is unable to 
remove phosphate from the body adequately) and manage symptoms and comorbid 
diseases. Dialysis pill burden is ranked as one of the highest among chronic illnesses 
(Chiu et al., 2009). Patients take 10 to 12 different types of medications and one fourth of 
dialysis patients take more than 25 pills per day (Chiu et al., 2009; Manley et al., 2004). 
Medications have distinct requirements for mode, timing and amount of intake. The 
complexity of medication regimen significantly increases patients’ likelihood of 
nonadherence (Chiu et al., 2009).  
A total of 2% to 30% PD patients fail to take their prescribed medication as 
instructed (Holley & DeVore, 2006; Katzir et al., 2010; Lam et al., 2010; Russo et al., 
2006), whereas 17% to 99% HD patients do not adhere to their prescribed medication 
(Curtin, Svarstad, & Keller, 1999; Lin & Liang, 1997). Age, pill burden, health literacy, 
health beliefs, personality, social support, and patient satisfaction have been cited as 
important factors affecting medication nonadherence (Browne & Merighi, 2010; 
Karamanidou, Clatworthy, et al., 2008). Important barriers to medication adherence 
include non user-friendly drug compound, feeling of discomfort, forgetfulness, 
polypharmacy and patient ignorance (Lindberg & Lindberg, 2008).  
Inadequate control of phosphorus level is linked with several risk factors for 
cardiovascular disease, such as elevated blood pressure, hyperkinetic circulation, 
increased cardiac work, and high arterial tensile stress (Marchais, Metivier, Guerin, & 
London, 1999). While hyperkalemia (high potassium) is a common problem among HD 
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patients, hypokalemia (low potassium) is profound among PD patients because there is 
greater filtration of potassium from blood to dialysate during the dialysis process in PD 
than HD (Factor, 2007; Khan, Bernardini, Johnston, & Piraino, 1996). Potassium < 3.5 
mmol/l is associated with increased mortality, risk of peritonitis and poor nutritional 
status (Chuang, Shu, Yu, Cheng, & Chen, 2009; Szeto et al., 2005) and can be managed 
effectively with potassium supplements or increasing dietary potassium intake. No 
studies have investigated nonadherence to potassium supplements among PD patients.  
Nonadherence to Diet 
Because dialysis does not restore functioning levels comparable to a health kidney, 
dietary restrictions are often used together with medications to prevent the increment of 
certain elements, such as sodium, phosphorus and protein, in the body. Dietary restriction 
is the most distressing part of dialysis regimen (Durose, Holdsworth, Watson, & 
Przygrodzka, 2004; Lam et al., 2010), probably because it involves profound alterations 
to individuals’ lifestyles. Only two studies investigated dietary nonadherence in PD 
patients and found that 62% to 77.1% of patients did not follow their dietary guidelines 
(Chen, Lu, & Wang, 2006; Lam et al., 2010). The prevalent rates of dietary nonadherence 
in HD patients varied from 24% to 81.4% (Kara, Caglar, & Kilic, 2007; Kugler, 
Vlaminck, Haverich, & Maes, 2005; Lin & Liang, 1997; Vlaminck et al., 2001).   
Factors affecting dietary nonadherence have not been adequately examined. One 
study in Hispanic patients identified knowledge of diet, language, food consumption 
frequency, socioeconomic status, family support and attitudes toward the renal diet as 
important factors related to dietary nonadherence (Morales Lopez, Burrowes, Gizis, & 
Brommage, 2007). Another study revealed that younger male patients and smokers were 
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more likely to be nonadherent to diet and fluid restrictions (Kugler et al., 2005). Since 
poor understanding with dietary contents was an important reason for nonadherence, 
using menu suggestion was found effective in reducing dietary nonadherence (Chen et al., 
2006). Nonadherence with salt and fluid was a critical reason for PD drop-out 
(Kawaguchi et al., 2003).  
Intentional and Unintentional Nonadherence 
Increasing knowledge is a standard way employed to reduce nonadherence in 
intervention programmes. However, nonadherence is problematic even among those with 
good knowledge (Lee & Molassiotis, 2002; Nerbass et al., 2010). Clarifying causes of 
nonadherence and intervening accordingly may be more cost-effective. Two broad 
categories have been proposed to classify causes of nonadherence: intentional and 
unintentional (Clifford, Barber, & Horne, 2008). This “intentional-unintentional” 
typology is predominantly used in investigating medication-taking behaviors (Daleboudt, 
Broadbent, McQueen, & Kaptein, 2010; Unni & Farris, 2011). Both forms of 
nonadherence have been observed in dialysis patients (McCarthy, Cook, Fairweather, 
Shaban, & Martin-McDonald, 2009; Nerbass et al., 2010; Polaschek, 2007), although no 
attempt has been made to document their prevalent rates. Unintentional nonadherence is a 
passive process, like forgetting to take medication or failing to recognize what are 
contained in food when eating. Patients are usually not aware of their deviation from 
treatment guidelines when it occurs. Factors such as complexity of treatment and disease 
severity contribute to unintentional nonadherence (Schuz et al., 2011). Intentional 
nonadherence is an active, decision-making process. Patients deliberately adjust their 
regimen to suit their needs, like forgoing medications to avoid side effects. Intentional 
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nonadherence is especially likely to occur if patients experience consequences as a result 
of adherence (e.g., dangerous drug interactions) or if patients are not well-informed and 
henceforth feel uncertain about the effectiveness of treatment (Schuz et al., 2011). There 
is good evidence suggesting that unintentional nonadherence occurs more often than 
intentional nonadherence in other populations (Rees, Leong, Crowston, & Lamoureux, 
2010; Sewitch et al., 2003; Unni & Farris, 2011). 
 A phenomenological study in another type of chronic illness identified 
forgetfulness, accidentally overdose and the unavailability of medication as reasons for 
unintentional nonadherence and intentional nonadherence was mainly caused by side 
effects, social activities, eating out, drinking alcohol or traveling (Eliasson, Clifford, 
Barber, & Marin, 2011). To the best of our knowledge, no studies concerning ESRD 
patients have distinguished intentional and unintentional nonadherence.  
Nonadherence on APD vs. CAPD  
Only one known study compared nonadherence difference between APD and 
CAPD patients (Bernardini et al., 2000). Home visit supply inventories were used to 
evaluate nonadherence to dialysis exchanges in this study and PD modality was identified 
as an independent predictor of nonadherence, with more nonadherence reported in CAPD 
than APD patients. 
Limitations of Previous Studies on Nonadherence in PD Patients 
As can be seen from Table 1, nonadherence levels in PD patients are relatively 
understudied compared to outcomes such as quality of life. Seventeen studies could be 
retrieved but these present several limitations. Most of these studies focused on 
nonadherence to dialysis and medication, overlooking nonadherence in relation to dietary 
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recommendations for PD patients. Although changes in diet are essential for management 
of conditions to ensure good clinical outcomes, little is known on rates of nonadherence 
with respect to dietary recommendation in this population. Recruited study samples were 
very small, which limits generalizability of findings. Only four studies had sample sizes 
above 100. Methodological criteria to define nonadherence in some studies are 
questionable. For instance, two studies defined nonadherence as creatinine excretion 
(CrEx) > 1.24 and this was later found to be an unreliable marker of nonadherence (Blake, 
Spanner, McMurray, Lindsay, & Ferguson, 1996). No previous studies used traditional 
biochemical markers (e.g., potassium, phosphate) to measure nonadherence in PD 
patients. Moreover, no studies have compared nonadherence outcomes in APD and 
CAPD. The majority of studies were forced to merge between APD and CAPD groups 
due to small sample sizes or were only based on CAPD patients. Nonadherence rates in 
APD patients were hence either not assessed or reported together with CAPD patients, so 
the question of which PD modality may be associated with less nonadherence remains 
largely unanswered. Lastly, no studies in PD patients have looked at intentional and 
unintentional nonadherence despite their important implications for intervention. 
Determinants of Nonadherence 
Previous studies on determinants of nonadherence tend to focus on demographical 
and clinical variables, overlooking the effects of psychosocial variables (Karamanidou, 
Clatworthy, et al., 2008; Russell, Knowles, & Peace, 2007). However, identifying 
demographical and clinical associates of nonadherence is of limited use in clinical 
applications as these factors are usually not modifiable (Sensky et al., 1996). Moreover, it 
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has been suggested that psychosocial factors are stronger determinants of nonadherence 
than demographical and clinical variables (Karamanidou, Clatworthy, et al., 2008). 
Therefore, it is imperative to examine the effects of psychosocial factors on 
nonadherence. This study focuses on three psychosocial variables: health beliefs, 
emotional distress and quality of life.  
Health Beliefs 
Little data is available about the effects of beliefs about medicines on 
nonadherence in ESRD patients. However, the association between beliefs about 
medicines and nonadherence to medication is well-supported in other populations 
(Daleboudt et al., 2010; Horne & Weinman, 1999; Schuz et al., 2011; Unni & Farris, 
2011). In a study involving 324 patients from different chronic conditions, the difference 
between perceived necessity of the prescribed medication and perceived concerns about 
the medication (e.g., side effects, long-term dependence) was found to be an independent 
predictor of medication nonadherence, accounting for a good portion (19%) of the 
variance (Horne & Weinman, 1999). Concern beliefs and necessity beliefs appear to have 
different roles in determining intentional and unintentional nonadherence. Concern 
beliefs have been reported to affect both intentional and unintentional nonadherence 
(Daleboudt et al., 2010; Unni & Farris, 2011), whereas necessity beliefs were mainly 
associated with intentional nonadherence (Schuz et al., 2011; Unni & Farris, 2011). 
There is ample evidence suggesting that self-efficacy is correlated with 
nonadherence to fluid, medication and diet in dialysis patients (Brady, Tucker, Alfino, 
Tarrant, & Finlayson, 1997; Christensen, Wiebe, Benotsch, & Lawton, 1996; Eitel, 
Friend, Griffin, & Wadhwa, 1998; Lindberg & Fernandes, 2010; Oka & Chaboyer, 2001; 
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Rosenbaum & Ben-Ari Smira, 1986; Schneider, Friend, Whitaker, & Wadhwa, 1991; 
Zrinyi et al., 2003). The impact of self-efficacy on nonadherence to dialysis exchanges is 
however, yet to be determined. A recent study consisting of 133 HD patients reported 
significantly less fluid intake in patients with high self-efficacy than patients with low 
self-efficacy (Lindberg, Wikstrom, & Lindberg, 2010). Similarly, another study involving 
a large group of HD patients associated self-efficacy with dietary nonadherence based on 
self-report and biochemical markers (Zrinyi et al., 2003).  
Emotional Distress 
Depression has been found to be associated with nonadherence (Brownbridge & 
Fielding, 1994; Cukor, Rosenthal, Jindal, Brown, & Kimmel, 2009; De-Nour & Czaczkes, 
1976). Depression may have a direct effect on nonadherence as symptoms may manifest 
as reduced appetite, excessive fatigue and a lack of energy which limit patients’ ability to 
adhere (McCarthy et al., 2009). Depression may also have an indirect effect on 
nonadherence through beliefs and cognitions. Depressed patients tend to have negative 
thoughts and feel hopeless and despair about self, world and future (Dekker et al., 2011). 
It is very likely that depressed patients devaluate their ability to cope with their diseases 
(i.e., having low self-efficacy), underestimate the effectiveness of their treatment and 
hold exaggerated concerns about possible disruptive effects of their treatment and thus 
show nonadherence behaviors (DiMatteo, Lepper, & Croghan, 2000). Given that previous 
intervention programmes targeting depression tend to have low response rates (Wuerth et 
al., 2005), identifying mediators between depression and nonadherence has the potential 




Health beliefs appear to be important mediators between depression and 
nonadherence in other populations (Chao, Nau, Aikens, & Taylor, 2005; Sacco et al., 
2007; Sacco et al., 2005; Schoenthaler, Ogedegbe, & Allegrante, 2009). For instance, a 
study involving 445 patients with diabetes reported that depression affected 
nonadherence mainly via perceived side effects, perceived general barriers, and self-
efficacy (Chao et al., 2005). Given that depression is significantly associated with health 
beliefs (Devins et al., 1982; Tsay & Healstead, 2002) and health beliefs, as stated above, 
are commonly associated with nonadherence. It is highly probable that self-efficacy also 
mediates the depression-nonadherence relationship in dialysis patients. This hypothesis 
was tested in this study. Anxiety was also found to be associated with nonadherence 
(Brownbridge & Fielding, 1994). The relationships among anxiety, health beliefs and 
nonadherence are rarely explored in literature and were also examined in this study.  
Quality of Life 
Only two studies associated quality of life with nonadherence (DeOreo, 1997; 
Pakpour et al., 2010) and the direction of this association is not clear. DeOreo (1997) 
studied 1000 HD patients and revealed that physical quality of life was higher, but mental 
quality of life was lower in patients who skipped more than two treatments per month 
than other patients. In contrast, Pakpour et al. (2010) reported a positive association 
between physical quality of life and adherence and no association between mental quality 





Limitations of Previous Studies 
Previous studies have shed some light on outcomes related to PD yet present with 
several shortcomings that limit generalizability of findings to other PD populations. 
The majority of studies comparing outcomes in APD and CAPD have focused 
exclusively on clinical endpoints such as peritonitis, morbidity and mortality. 
Psychological and behavioral outcomes, such as emotional distress, quality of life, and 
nonadherence, have largely been overlooked. 
Studies that explored psychological outcomes have very small sample sizes (not 
exceeding 70) and some merge across APD and CAPD into one group. There are also 
conceptual and method limitations in the measures of nonadherence such as using 
unreliable biochemical markers (e.g., creatinine excretion).  
Most of the studies on PD patients have focused on nonadherence yo dialytic 
prescriptions (e.g., missing exchanges, shortening dialysis time) or prescribed medication, 
overlooking the lifestyle aspects of treatment such as dietary recommendations. No 
studies have explored intentional and unintentional nonadherence. 
The factors that may explain/predict nadherence difficulties and self-care 
behaviors in patients maintained on PD are also not well understood. Psychosocial factors, 
which are more proximal predictors of nonadherence and more amendable to 
interventions, receive little attention in literature than demographical and clinical 
variables. 
Furthermore, to the best of our knowledge, there have been no studies on 
psychosocial outcomes in PD patients in Singapore. It is hard to extrapolate or generalize 
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experience gained in other countries to Singapore due to the local variation in the 
important factors (e.g., sociopolitical, economic, cultural).  
Study Objectives 
 To assess the effect of PD modality (APD or CAPD) on health beliefs, 
emotional distress and quality of life 
 To document overall, intentional and unintentional nonadherence rates to 
different aspects of the therapeutic regimen (i.e., dialysis, medication and diet) 
 To identify psychosocial determinants of nonadherence 
Study Hypotheses 
Two main hypotheses were suggested for this study based on previous findings: 
Hypothesis 1 focuses on the prevalence of nonadherence among PD patients. 
Based on what has been discussed above, we proposed Hypothesis 1a that nonadherence 
to dietary restrictions is higher than nonadherence to medical aspects of treatment 
regimes, namely dialysis exchanges and medication. The exact differences between the 
three components could not be predicted, since past studies used different definitions and 
measures of nonadherence. Hypothesis 1b is that unintentional nonadherence is expected 
to occur more than intentional nonadherence, as explained above. 
Hypothesis 2 is regarding determinants of nonadherence. Hypothesis 2a is that 
positive health beliefs (i.e., high necessity beliefs, low concern beliefs and high self-
efficacy) are expected to be associated with less nonadherence; Hypothesis 2b that more 
emotional distress is expected to be associated with more nonadherence.  
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No apriori directional hypotheses were formulated regarding psychosocial (i.e., 
health beliefs, emotional distress, quality of life and nonadherence) differences between 
APD and CAPD groups as well as the association between quality of life and 







This was a cross-sectional study. Participants were recruited from the Peritoneal 
Dialysis Center, Singapore General Hospital (SGH) from October 2010 to June 2011.  
Inclusion Criteria 
Patients were recruited if they met the following criteria: 
1. In the PD programme for a minimum of 3 months; 
2. Aged 21 years or over;  
3. Able to communicate verbally with research assistants; 
4. Able to provide informed consent. 
Recruitment Process 
Patients were randomly approached by research assistants while awaiting 
consultations with nephrologists at the PD center. All approached patients were given a 
short introduction about the purpose and procedure of our study. After a brief screening, 
patients failing to meet the inclusion criteria were excluded from participation. The rest 
of the eligible patients were given an information sheet listing out details of the study 
(see Appendix B). It was made clear to the patients that participation was strictly 
voluntary and confidential. Any additional questions were answered appropriately before 
patients made their decisions concerning participation. The overall recruitment process is 












                                    
                                     Figure 3. Flowchart of the recruitment process. 
 
One hundred and ninety nine patients were approached at the PD center. Of the 
199, 16 failed to meet the inclusion criteria and were excluded. Of the eligible 183, 37 
declined invitation to participate. Of the 146 who agreed to participate, n = 2 patients 
dropped out due to sudden decline in health status. Thus, our final sample consisted of 
144 PD patients (response rate = 79%). Written informed consent (see Appendix C) was 
obtained from patients prior to questionnaire administration. Standard to research 
conducted in busy clinical settings, study assessments were scheduled based on patients’ 
preference, availability and convenience. Questionnaires were therefore completed and 
returned to research in the following ways (data only available for n = 132 patients):  
1. Completing the questionnaires at the hospital while awaiting consultations with 






n = 16 





n = 2 
Declined 
n = 37 
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2. Bringing the study information sheet and questionnaires back to further 
consider about it and posting their questionnaires back to us if they wanted to (n = 37). 
3. Indicating a preferred time and allowing a research assistant to administer a 
home visit (n = 62).  
Study Instruments 
Demographics  
Demographics (age, gender, marital status, ethnicity, education, employment 
status, housing condition and time on dialysis) were collected with self-designed 
questions (see Appendix D). Patients were also inquired about who were taking a more 
active role (self vs. carer) in managing their disease. 
Medical Information 
Medical information (prescribed medicines, comorbid diseases, primary cause of 
ESRD, PD modality, creatinine, potassium, phosphate, albumin, hemoglobin and Kt/V, 
see Appendix E) was abstracted from medical records by nursing staff in the participating 
clinic.  
Charlson Comorbidity Index (CCI). CCI score was calculated using the validated 
method suggested by Beddhu et al. (2002) for PD patients. Included comorbid diseases 
were coronary artery disease, heart failure, peripheral vascular disease, cerebrovascular 
disease, dementia, chronic pulmonary disease, connective tissue disorder, peptic ulcer 
disease, diabetes, hemiplegia, moderate or severe renal disease, tumor, leukemia, 
lymphoma, liver disease, metastatic solid tumor and AIDS. One point was added to the 
CCI score for each decade of > 40 years of age. Patients were classified into low, 
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moderate and high comorbidity groups based on being positioned before the 33rd, 
between 33rd and 66th, and after the 66th percentiles of CCI scores respectively.  
Health Beliefs Measures  
The Beliefs About Medicines Questionnaire (BMQ).Patients’ medicine beliefs 
were assessed with the BMQ (Horne, Weinman, & Hankins, 1999). It consists of a 
necessity subscale and a concerns subscale (5 items for each), measuring perceived 
necessity/usefulness about taking the prescribed medication and perceived disruptive 
effects/dependence effects caused by the medication, respectively. Aggregate scores 
(range = 5−25) were used, with higher scores indicating more necessity or concern 
beliefs. The difference between the necessity score and the concerns score was calculated 
for each individual. If this value was positive, it indicated more necessity beliefs over 
concern beliefs. Otherwise, it indicated necessity beliefs equal to or lower than concern 
beliefs. Both subscales showed high reliability in our study. Necessity subscale 
Cronbach’s α = .81 and concerns subscale Cronbach’s α = .77.    
Self-efficacy. It was assessed with questions adapted from the Self Efficacy for 
Managing Chronic Disease Scale developed by Lorig et al. (2001). It consists of a set of 
13 items, asking patients to rate their confidence in accomplishing various tasks involved 
in managing their illness on a 10-point Likert scale (e.g., “How confident are you that 
you can perform your PD exchanges as instructed by your doctor?” 1 = not at all 
confident, 10 = totally confident). The first six items (Cronbach’s α = .89) were from the 
original scale, measuring generic self-efficacy. We also designed additional seven items, 
one item measuring dialysis self-efficacy, two measuring medication self-efficacy 
(Cronbach's α = .61) and four measuring dietary self-efficacy (Cronbach's α = .87). Mean 
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scores (range = 1−10) were used, with higher scores denoting higher levels of self-
efficacy.  
Emotional Distress Measures 
The Hospital Anxiety and Depression Scale (HADS). Symptoms of depression and 
anxiety were assessed using the HADS (Zigmond & Snaith, 1983). HADS is a widely 
used instrument, consisting of an anxiety subscale (7 items) and a depression subscale (7 
items). Patients were asked to rate their degree of anxiety and depression in the past 14 
days on a 4-point Likert scale (0 = yes, definitely, 3 = no, not at all). Aggregate score for 
each subscale was derived, ranging from 0 to 21. A higher score signifies higher level of 
anxiety or depression. Both the depression and anxiety subscales demonstrated 
satisfactory reliability. Anxiety subscale Cronbach’s α = .83. Depression subscale 
Cronbach’s α = .76. The aggregate scores were classified into three categories: normal 
(0−7), borderline (8−10) and abnormal (11−21) (Thompson et al., 2000). HADS has been 
validated and applied successfully in measuring anxiety and depression among ESRD 
patients (Loosman, Siegert, Korzec, & Honig, 2010; Riezebos, Nauta, Honig, Dekker, & 
Siegert, 2010). This measure was preferred over other instruments as it precludes somatic 
symptoms such as fatigue, anorexia, and weight loss (Fernandes et al., 2010) which may 
confound with symptoms related to renal condition and uremia.  
The Revised UCLA Loneliness Scale. Loneliness was assessed with the Revised 
UCLA Loneliness Scale (Russell, Peplau, & Cutrona, 1980). It includes 20 items. 
Patients responded to the questions on a 4-point Likert scale. The aggregate score (range 
= 20−80) was calculated, with higher score indicating a higher degree of loneliness. This 
scale had high reliability on the study (Cronbach’s α =.85). The loneliness scores were 
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classified into four categories: low (20−34), moderate (35−49), moderately high (50−64) 
and high (65−80) (Perry, 1990). 
Quality of Life Measures 
Three measures were used to capture all aspects of quality of life: generic health 
related quality of life, disease specific quality of life and subjective global quality of life. 
The Kidney Disease Quality of Life Short Form (KDQOL-SF). Disease specific 
quality of life was assessed with the KDQOL-SF (Hays et al., 1997), a special instrument 
targeting ESRD patients. The original questionnaire includes the 36-item Short-Form 
Health Survey (SF-36), supplemented by kidney disease-specific questions. SF-36 was 
replaced by its shorter version, the 12-item Short-Form Health Survey (SF-12) in our 
study to reduce burden of completion for respondents. SF-12 is a generic health related 
quality of life measure. Two summary scores, physical component summary score (PCS) 
and mental component summary score (MCS), were calculated using the standard way 
(Ware, Kosinski, Keller, & Institute, 1998). The eight domain scores used in SF-36 were 
not calculated, as suggested in the SF-12 manual (Ware et al., 1998). Conveniently, 
Singapore’s SF-36 PCS and MCS norms are available (Thumboo et al., 2001) and a 
calculator is provided online (http://www.singhealth.com.sg/Research/ 
HealthServicesResearch/OurServices/OutcomesResearch/Documents/HSRSingHealthSF
36calculator-v3-beta.xls) to calculate PCS and MCS norms after adjusting for age, gender 
and ethnicity. It has been justified to use SF-36 norms to interpret SF-12 results (Brown 
et al., 2010). The kidney disease specific part includes 31 items to measure disease 
specific quality of life, encompassing 6 domains: symptoms, effects of kidney disease, 
burden of kidney disease, patient satisfaction, staff encouragement and social support. All 
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6 domain scores were transformed to be varying from 0 to 100. Higher scores signify 
better quality of life for all KDQOL-SF domains. Table 2 provides a summary for the 
KDQOL domains regarding their number of items, reliability coefficients on the study 
and interpretations. All KDQOL-SF subscales used in this study showed acceptable 
reliability (range = .66 to. 85). KDQOL-SF has been verified in 1180 Singapore HD 
patients and showed satisfactory psychometric properties (Joshi, Mooppil, & Lim, 2010). 
The World Health Organization Quality of Life Instrument, Short Form 
(WHOQOL-BREF). Subjective global quality of life was measured with the WHOQOL-
BREF (Herrman et al., 1998). This instrument includes 26 items. Twenty four out of the 
26 items were used to assess patients' quality of life in four domains: physical health, 
psychological health, social relations, and environment. Each domain score ranged from 
4 to 20, with higher score signifying better quality of life. Table 3 displays the number of 
items, reliability coefficients and interpretations for the four domains. All domains 
showed acceptable reliability, with Cronbach’s α ranging from .61 to .81. WHOQOL-
BREF has been validated in 23 countries consisting of 11,830 sick and well adults 
(Skevington, Lotfy, & O'Connell, 2004) and the norms reported in this article were 




Table 2: Number of Items, Reliability Coefficients and Concepts Measured by KDQOL-SF Domains 
Number of Items, Reliability Coefficients and Concepts Measured by the KDQOL-SF 
Domains 
 No. of items Cronbach’s α Concept measured 
SF-12 PCS 6 .66 Physical component summary score 
SF-12 MCS 6 .72 Mental component summary score 
Symptom list  12 .85 Extent that patients are bothered by 
dialysis-related symptoms such as chest 
pain, cramps and itchy skin 
Effects of kidney 
disease  
8 .85 Extent that patients are bothered by daily 
life issues such as fluid restriction, dietary 
restriction, inability to travel and 
dependence on medical staff 
Burden of kidney 
disease  
4 .79 Extent that patients are bothered by time 
consumed by dialysis, its intrusiveness and 
burden on family 




2 .84 Extent to which renal staff encourage 
patients to be independent and support 
patients in dealing with their kidney disease
Social support  4 .71 Patients’ satisfaction with togetherness and 
support from family and friends 
Note. KDQOL-SF = Kidney Disease Quality of Life Short Form. SF-12 = 12-item Short-
Form Health Survey. PCS = physical component summary score. MCS = mental 
component summary score. Cited from “Psychosocial predictors of non-compliance in 
haemodialysis and peritoneal dialysis patients,” by N. G. Kutner, R. Zhang, W. M. 
McClellan, & S. A .Cole, 2002, Nephrology, Dialysis, Transplantation, 17, p. 95. Used 
with permission from the Oxford University Press (see Appendix F). 
 
("WHOQOL-BREF Introduction, Administration, Scoring and Generic Version of the 
Assessment, Field Trial Version," 1996 )
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Table 3: Number of Items, Reliability Coefficients and Concepts Measured by WHOQOL-BREF Domains 
Number of Items, Reliability Coefficients and Concepts Measured by the WHOQOL-
BREF Domains 
      Domain Concepts measured  
Physical health 
7 items,  
Cronbach’s α = .80 
Activities of daily living 
Dependence on medicinal substances and medical aids 
Energy and fatigue 
Mobility 
Pain and discomfort 
Sleep and rest 
Work Capacity 
Psychological health 
6 items,  
Cronbach’s α = .81 




Spirituality / Religion / Personal beliefs 
Thinking, learning, memory and concentration 
Social relations 
3 items 






Cronbach’s α = .76 
Financial resources 
Freedom, physical safety and security 
Health and social care: accessibility and quality 
Home environment  
Opportunities for acquiring new information and skills 
Participation in and opportunities for recreation / leisure activities 
Physical environment (pollution / noise / traffic / climate) 
Transport 
Note. WHOQOL-BREF = World Health Organization Quality of Life Instrument, Short 
Form. Cited from “WHOQOL-BREF Introduction, Administration, Scoring and Generic 
Version of the Assessment, Field Trial Version,” by M. Rapley, 1996, World health 





No single method of measuring nonadherence is perfect. For this study, we 
elected to use self-report as the primary outcome and serum concentrations of potassium, 
phosphate and albumin as a secondary outcome. 
Self-reported nonadherence. A dialysis specific measure (see Appendix H) was 
designed for the purpose of this study to assess self-reported nonadherence to the PD 
regimens. The scale contains 9 items, measuring nonadherence to prescribed dialysis 
exchanges (3 items), medication (3 items) and diet (3 items). The three questions used to 
assess medication nonadherence were adapted from Horne and Weinman (1999): 
1. “How often do you follow this regime?” (overall nonadherence) 
2. “Some people forget to take their medicines. Overall, how often does this 
happen to you?” (unintentional / accidental nonadherence) 
3. “Some people decide to miss out a dose of their medication or adjust it to suit 
their own needs. Overall, how often do you do this?” (intentional / deliberate 
nonadherence) 
Similar formats were used for measuring nonadherence to dialysis and diet. But 
for nonadherence to diet, one more item was added before the three questions: “Have you 
been asked to follow a diet?” If patients answered “no” to this question, they did not need 
to answer the rest questions regarding nonadherence to diet. Potential responses to each 
question are from 1 (= never) to 5 (= very often). The score for the first item (“How often 
do you follow this regime?”) was reversed. Thus higher scores indicated greater 
nonadherence for all questions. The overall nonadherence scale showed good reliability 
in this study (Cronbach's α = .77). Nonadherence was defined as at least rarely deviating 
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from treatment regimen. Two additional questions were developed in accordance with the 
criteria defined in the USRDS (1997) survey of dialysis morbidity and mortality to assess 
patients' behavioral nonadherence to dialysis guidelines:  
1. “During the last 4 weeks, how many times have you skipped/missed one of your 
PD sessions/exchanges?” 
2. “During the past 4 weeks, how many times have you shortened your PD session 
by 10 minutes?” 
These two items were treated as stand alone items for the analyses, with higher scores  
signifying more frequent nonadherence to dialysis exchanges/regimen. 
Nonadherence based on biochemical markers. Three biochemical markers (i.e., 
potassium, phosphate and albumin) were used to estimate nonadherence to diet and 
medication. Nonadherence was defined as levels outside clinical cut-offs/ targets: 
potassium < 3.5 mmol/l (signifying nonadherence to dietary guidelines or taking 
potassium supplements), phosphate > 1.78 mmol/l (signifying nonadherence to dietary 
guidelines or phosphate binders), and albumin < 3.5 g/dl (signifying malnutrition and 
thereby dietary nonadherence). These cut-off values have been widely used in previous 
studies (Moe et al., 2005; Plantinga et al., 2004; Szeto et al., 2005) and were confirmed 
by the key PD consultants in patient care as clinical targets for the patient population.  
Study Languages 
Patients were free to choose their preferred language in this study. All study 
instruments were available in English and Chinese versions. The HADS, UCLA 
loneliness Scale, KDQOL-SF and WHOQOL-BREF have been translated into Chinese 
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and validated in other studies (Fang, Hao, & Li, 1999; Leung, Ho, Kan, Hung, & Chen, 
1993; Li, 1998; Liu, 1993). The BMQ and demographical, self-efficacy and adherence 
questionnaires have no standardized Chinese versions available. They were translated by 
a research assistant proficient in both English and Chinese. All patients who could only 
speak Chinese dialects (e.g., Hokkien) or Malay were interviewed with assistance from 
their family members or by research assistants.  
Data Analysis 
Missing Data 
Table 4 shows the distribution of missing items. As missing items were small in 
number and randomly distributed, mean imputations were used if at least half of the items 
in the same domain were answered by the participants (missing Kt/V values were not 
imputed). 
Table 4: Distribution of Missing Values 
Distribution of Missing Values  
 Frequency Percent 
Kt/V 4 2.8 
BMQ 6 0.4 
UCLA loneliness 1 0.03 
SF-12 2 0.1 
WHOQOL-BREF 3 0.08 
Nonadherence measures 1 0.08 
 Note. BMQ = Beliefs about Medicines Questionnaire. UCLA loneliness = Revised 
UCLA Loneliness Scale. SF-12 = 12-item Short-Form Health Survey. WHOQOL-BREF 






Descriptives. Descriptive statistics included medians, means and standard 
deviations for continuous variables and frequencies and percentages for categorical 
variables.  
Univariate analyses. Kolmogorov-Smirnov tests were used to assess the 
normality of variable distribution. Means were compared with independent t tests, paired 
t tests, ANOVA or ANCOVA and percentages were compared with χ2 tests unless 
otherwise specified. When data were not normally distributed, non-parametric tests 
(Mann-Whitney tests, Wilcoxon signed-rank tests, Kruskal-Wallis tests or Fisher's exact 
tests) were used instead and noted. Spearman rank correlation coefficients were 
calculated to denote the correlations among variables. 
Multivariate analyses. Hierarchical stepwise multiple linear regressions were used 
to identify important predictors of self-reported nonadherence levels. Hierarchical 
stepwise logistic regressions were used to identify significant predictors of nonadherence 
based on biochemical markers. Entry and removal criteria were fixed at p = .05 and p 
= .10 respectively. The large number of variables measured increased the risk of type I 
error. Therefore, the first stage of model selection involved initial screening using 
univariate tests of associations (e.g., ANOVAs, Mann–Whitney tests, correlations or χ2 
tests as appropriate) to identify demographical, clinical and psychosocial variables 
associated with nonadherence indices. A forward stepwise procedure was used to select 
variables from those that were significant at .05 on initial screening. 
Mediation analyses. Figure 4 is used to illustrate how to test the existence of 




represents the mediator. Based on the suggestions of Barron and Kenney (1986), the X-Y 
relationship is totally mediated by M if (1) there is a significant relationship between X 
and Y before controlling for M (total effect, represented by c path in Figure 4); (2) M is 
significantly associated with X (a path); (3) the influence of M on Y (b path) is 
significant; (4) the effect of X on Y becomes zero after controlling for M (direct effect, 
represented by cʹ path). Indirect effect is the difference between total effect and direct 










               Figure 4. A simple mediation model.  
 
We tested mediation effects with the use of a SPSS macro (available at 
www.quantpsy.org ) provided by Preacher and Hayes (2008). It performs the four steps 
recommended by Baron and Kenny (1986) simultaneously. The significance of indirect 
effect can be estimated through a nonparametric method (bootstrapping) contained in this 
Macro. It produces a 95% confidence interval (CI) for indirect effect. If this 95% CI does 
not include zero, it indicates that indirect effect is significantly different from zero. This 
statistic method (bootstrapping) is highly recommended in literature (Shrout & Bolger, 









error, and allows for multiple mediators to be tested simultaneously after controlling for 
covariates (Buffardi & Campbell, 2008). Parameters were estimated based on 1000 
bootstrap samples in the current study. 
Specifically, we created and tested all possible mediation effects of health belief 
variables (i.e., medicine beliefs and/or self-efficacy) on the relationship between 
emotional distress (i.e., depression, anxiety or loneliness) and nonadherence in three steps, 
similar to previous studies (Buffardi & Campbell, 2008; Sebire, Standage, & 
Vansteenkiste, 2009). Firstly, if an emotional factor significantly correlated with one of 
the six nonadherence measures (intentional/unintentional nonadherence to 
dialysis/medication/diet) after controlling for covariates, this emotional factor was chosen 
as X (the predictor) and the corresponding nonadherence measure was chosen as Y (the 
dependent variable). Secondly, if a health belief variable significantly correlated with 
both X and Y after controlling for covariates, it was chosen as M (the mediator). If there 
was more than one health belief variable meeting this criteria, they were entered into the 
same model and tested simultaneously in order to reduce number of tests and type I error. 
Thus a mediation model in our study contained only one predictor and one dependent 
variable, but allowed for multiple mediators. Finally, we used the SPSS macro provided 
by Preacher and Hayes (2008) to examine the significance of the total effect, direct effect 
and indirect effect of emotional distress (X) on nonadherence (Y). 
Statistical significance level was set at .05 for all procedures. Bonferroni α-
adjustment was applied for all post-hoc comparisons. All the procedures were performed 




Required sample size. Required sample sizes were calculated with G*power 3.1 
(Faul, Erdfelder, Buchner, & Lang, 2009) corresponding to two primary study goals: (a) 
comparing APD and CAPD outcomes (using independent t tests or Mann-Whitney tests) 
and (b) identifying predictors of intentional and unintentional nonadherence (using 
multiple linear regressions). A sample size of 64 for each group is required to detect a 
medium effect size of d = .5,  = .05, power (1) = .8 for two-tailed independent t test. 
A sample size of 67 for each group is required to detect a medium effect size of d = .5,  
= .05, power (1) = .8 for two-tailed Mann-Whitney test. For linear regression with 17 
predictors, a sample size of 146 is required to detect a medium effect size of 2 = .15,  
= .05, power (1) = .8.  
Ethics 
This study was approved by Centralized Institutional Review Board, SingHealth 
Research Facilities (see Appendix I).   
("Seventh Report of the Singapore Renal Registry, 2007/2008," 2010; "USRDS 2010 Annual Data Report," 2010; "The 







Fifty eight automated peritoneal dialysis (APD) and 86 continuous ambulatory 
peritoneal dialysis (CAPD) patients participated in the study (response rate = 79%).  
Table 5 summarizes the patients' demographic characteristics. The median age of 
the patients was 59 years (range = 21−89 years), close to the median age of 60 years for 
Singapore prevalent PD patients (SRR, 2010). Forty three percent of the patients were 
male and most patients (72%) were married.  
Comparisons between PD subgroups indicated that APD patients had been on PD 
for less time, χ2(2, N = 144) = 13.90, p = .001, and were significantly more likely to be 
employed, χ2(1, N = 144) = 6.66, p = .01 compared to CAPD respondents. No differences 
were found for other demographics (age, gender, marital status, ethnicity, education level, 
employment status and housing condition) between the two groups. These case-mix 
differences (i.e., time on dialysis and employment status) were entered as covariates in 
ANCOVA tests conducted to compare APD and CAPD patients, as long as they were 




Table 5: Demographical Characteristics of APD and CAPD Patients 




(n = 58) 
CAPD 
(n = 86) 
p 
Age in years 58.0 ± 12.9  55.6 ± 14.5 59.6 ± 11.5 .08 
Male 62 (43) 26(45) 36(42) .74 
Marital status     
  Married 103 (72) 37(64) 66 (77) .13 
  Widowed/divorced/single/ 
  other 
41 (28) 21(36) 20 (23)  
Ethnicity     
  Chinese 102 (71) 42 (72) 60 (70) .85 
  Malay/Indian/Other 42 (29) 16 (28) 26 (30)  
Education Level     
  Low 54 (38) 20(34) 34 (39) .23 
  Intermediate 54 (38) 19(33) 35 (41)  
  High 36 (24) 19(33) 17 (20)  
Employment status     
  Employed 38 (26) 22(38) 16 (19) .01 
  Unemployed 106 (74) 36(62) 70 (81)  
Housing condition     
  1−4 rooms flats 88 (61) 31(53) 57 (66) .29 
  5 rooms flats 35 (24) 16(28) 19 (22)  
  Condominiums or above 21 (15) 11(19) 10 (12)  
Time on dialysis     
  Less than 1 year 32 (22) 21(36) 11 (13) .001 
  1 to 2 years 20 (14) 10(17) 10 (12)  
  More than 2 years 92 (64) 27(47) 65 (75)  
 Note. Data expressed as M ± SD or n (%). APD = Automated Peritoneal Dialysis. CAPD 





Table 6: Clinical Characteristics of APD and CAPD Patients 




(n = 58) 
CAPD 
(n = 86) 
p 
Dependence on carer 36 (25) 16 (28) 20 (23) .70 
Pill burden 10.3 ± 2.6 10.2 ± 2.7 10.3 ± 2.5 .77a 
CCI 5.6 ± 2.0 5.3 ± 2.2 5.7 ± 1.9 .33a 
  Low ( ≤ 5) 72(50) 30(52) 42(49) .88 
  Moderate ( 6)  30(21) 11(19) 19(22)  
  High ( ≥ 7)  42(29) 17(29) 25(29)  
Primary cause of ESRD     
  Diabetes 62(43) 28(48) 34(39) .52 
  Hypertension 28(19) 8(14) 20(23)  
  Glomerulonephritis                   38(27) 16(28) 22(26)  
  Other 16(11) 6(10) 10(12)  
Creatinine (mmol/l) 0.87 ± 0.31 0.89 ± 0.33 0.85 ± 0.29 .39 
Potassium (mmol/l) 4.1 ± 0.7 4.1 ± 0.7 4.1 ± 0.6 .76 
Phosphate (mmol/l) 1.60 ± 0.54 1.68 ± 0.57 1.55 ± 0.51 .18 
Albumin (g/dl) 2.9 ± 0.5 2.9 ± 0.6 2.9 ± 0.5 .74 
Hemoglobin (g/dl) 10.76 ± 1.69 10.83 ± 1.58 10.72 ± 1.77 .72 
Kt/V 2.33 ± 0.99 2.39 ± 1.26 2.29 ± 0.76 .44a 
Note. Data expressed as M ± SD or n (%).APD = Automated Peritoneal Dialysis. CAPD 
= Continuous Ambulatory Peritoneal Dialysis. Dependence on carer = carer 
accomplishing most treatment tasks (e.g., performing dialysis). Pill burden = number of 








Table 6 displays patients' clinical characteristics. Seventy five percent of the 
patients were relatively independent, requiring minimum or no assistance in their 
treatment activities. Twenty five percent relied on their carers to accomplish most or all 
of the treatment tasks (e.g., performing dialysis). A median of 10 types of medicines were 
prescribed to the patients (M = 10.3, SD = 2.6, range = 5−17). Based on 33rd (≤ 5) and 
67th (> 6) percentiles of the CCI scores, 50% patients had moderate to high comorbidity. 
The most common causes of ESRD were diabetes (43%), glomerulonephritis (27%) and 
hypertension (19%). Patients were adequately dialyzed but malnourished, as suggested by 
a mean Kt/V level of 2.33 (SD = 0.99) and a mean albumin level of 2.9 (SD = 0.5) g/dl, 
respectively. There were no significant differences between APD and CAPD patients on 
any of the clinical parameters recorded (see Table 6). 
Health Beliefs 
BMQ 
Patients expressed strong beliefs in the necessity of their prescribed medication 
(M = 20.5, SD = 3.9) and a moderate level of concerns about the disruptive effects of the 
medication (M = 16.1, SD = 5.1) (Table 7).  
The necessity-concerns difference score was calculated through subtracting the 
concerns score from the necessity score for each individual. This difference score was 
positive (more positive evaluation of necessity beliefs vs. concern beliefs; necessity 
outweighing any concerns) in 73%, zero (equal necessity and concern beliefs) in 12% and 
negative (negative evaluation of need of medication vs. concerns; concerns outweighing 
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perceived need) in 15% of the patients. Mann-Whitney tests indicated no differences 
between APD and CAPD patients on necessity and concern beliefs. 
Table 7: Health Beliefs Results in APD and CAPD Patients CAPD Patients 




(n = 58) 
CAPD 
(n = 86) 
p 
BMQ     
  Necessity 20.5 ± 3.9 20.1 ± 4.0 20.7 ± 3.9 .21a 
  Concerns 16.1 ± 5.1 16.7 ± 4.7 15.7 ± 5.4 .40a 
SE     
  Generic SE 5.9 ±2.0 6.0± 2.3 5.8 ± 1.8 .76 
  Dialysis SE 8.9 ± 1.7 8.7 ± 2.1 9.1 ± 1.3 .53a 
  Medication SE 7.8 ± 1.9 7.2 ± 2.2 8.2 ± 1.6 .01a 
  Dietary SE 7.3 ± 2.1 7.1 ± 2.2 7.5 ± 2.0 .23a 
Note. Data expressed as M ± SD. Higher value indicates more necessity/concern beliefs 
or higher self-efficacy. APD = Automated Peritoneal Dialysis. CAPD = Continuous 
Ambulatory Peritoneal Dialysis. BMQ = Beliefs about Medicines Questionnaire. SE = 
self-efficacy. 
aMann-Whitney test.  
 
Self-efficacy  
Patients reported high self-efficacy in following dialysis (M = 8.9 out of possible 
10, SD = 1.7), medication (M = 7.8, SD = 1.9) and dietary guidelines (M = 7.3, SD = 2.1) 
and moderate generic self-efficacy in managing their illness (M = 5.9, SD = 2.0).   
Mann-Whitney tests indicated that mean medication self-efficacy was higher in 
CAPD (Mdn = 8.5) patients than APD (Mdn = 7.2) patients, U = 1873.0, p = .01. This 
was further confirmed by a ANCOVA test after controlling for time on dialysis and 
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Quality of Life 
KDQOL-SF 
Table 9 reports quality of life levels for the total PD sample as well as APD and 
CAPD subgroups. Results on the generic health related quality of life measure, i.e. SF-12, 
indicated that patients' mean PCS score of 35.7 (SD = 9.2) was significantly lower than 
the mean MCS score of 43.6 (SD = 11.0), t(143) = −7.16, p < .001. Both the mean PCS 
and MCS scores were significantly lower than the age-, gender- and ethnicity-adjusted 
Singapore norms (Thumboo et al., 2001) in one sample t tests (PCS norm 51.2, t[143] = 
−20.16, p < .001; MCS norm 50.3, t[143] = −7.25, p < .001), indicating that patients' 
quality of life was impaired in our sample, especially in the physical domain/well-being.   
Among kidney disease specific quality of life subscales, staff encouragement (M 
= 72.2, SD = 30.7) and social support (M =71.6, SD = 21.6) scored the highest (indicative 
of better quality of life scores), while on the other hand burden of kidney disease (M = 
32.4, SD = 26.5) scored the lowest. Thus, patients perceived a relatively high level of 
support from medical staff, family members and friends. They also felt severely bothered 
by time spent on dialysis, its intrusiveness and burden on family.  
Mann-Whitney or t tests were performed to compare KDQOL differences 
between APD and CAPD. APD (Mdn = 79.2) and CAPD (Mdn = 70.8) patients only 
scored differently on symptoms score, with marginally significantly less symptoms 
reported by APD patients, Mann-Whitney test U = 2005.5, p = .05. However, ANCOVA 
tests showed no quality of life differences (including symptoms) between the two groups 




Table 9: Quality of Life Outcomes in APD and CAPD Patients 




(n = 58) 
CAPD 
(n = 86) 
p 
KDQOL-SF     
  SF-12 PCS 35.7 ± 9.2 36.7 ± 9.9 34.9 ± 8.7 .26 
  SF-12 MCS 43.6 ± 11.0 44.0 ± 10.3 43.4 ± 11.6 .73 
  Symptoms 68.8 ± 19.4 72.0 ± 19.7 66.7 ± 18.9 .05a 
  Effects of kidney disease 67.0 ± 22.9 69.1 ± 22.9 65.6 ± 23.0 .37 
  Burden of kidney disease 32.4 ± 26.5 34.2 ± 27.2 31.2 ± 26.1 .57a 
  Patient satisfaction 65.7 ± 22.1 63.5 ± 21.0 67.2 ± 22.8 .46a 
  Staff encouragement 72.2 ± 30.7 74.6 ± 26.7 70.6 ± 33.1 .83a 
  Social support 71.6 ± 21.6 70.3 ± 22.4 72.5 ± 21.2 .43a 
WHOQOL-BREF     
  Physical health 11.7 ± 3.2 11.7 ± 3.1 11.6 ± 3.3 .93a 
  Psychological  health 13.0 ± 3.2 12.7 ± 3.4 13.3 ± 3.0 .28 
  Social relations 13.2 ± 3.4 13.0 ± 3.6 13.4 ± 3.3 .40a 
  Environment 13.6 ± 2.5 13.4 ± 2.9 13.8 ± 2.3 .32 
Note. Data expressed as M ± SD. Higher values indicates better quality of life. APD = 
Automated Peritoneal Dialysis. CAPD = Continuous Ambulatory Peritoneal Dialysis. 
KDQOL-SF = Kidney Disease Quality of Life Short Form. SF-12 = 12-item Short-Form 
Health Survey. PCS = physical component summary score. MCS = mental component 
summary score. WHOQOL-BREF = World Health Organization Quality of Life 




 The international mean scores (Skevington et al., 2004) for the physical health, 
psychological health, social relations and environment domains were 16.2 (SD = 2.9), 
15.0 (SD = 2.8), 14.3 (SD = 3.2) and 13.5 (SD = 2.6). The corresponding four domain 
scores in our study were 11.7 (SD = 3.2), 13.0 (SD = 3.2), 13.2 (SD = 3.4) and 13.6 (SD = 
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2.5), with the first three scores significantly lower than the norms (t[143] = −16.88, p 
< .001; t[143] = −7.51, p < .001; t[143] = −3.80, p < .001 respectively) and the last score 
equivalent to the normative mean (t[143] = 0.55, p = .58). Thus WHOQOL-BREF results 
indicated that patients’ physical, psychological and social relations, but not environment, 
quality of life was poorer than international norms.     
APD and CAPD patients did not score differently on any of the WHOQOL-BREF 
domains (Mann-Whitney, t tests or ANCOVA tests).  
Prevalence of Nonadherence 
Self-reported Nonadherence 
The percentages of patients reporting “never”, “rarely”, “sometimes”, “often” or 
“very often” deviating from their treatment recommendations for dialysis, medication and 
diet are depicted in Figure 8. A total of n = 12 patients reported no dietary restrictions, so 
dietary nonadherence outcomes were based on the rest 132 patients. Twenty percent, 47% 
and 75% of the patients reported at least rarely deviating from dialysis, medication and 
diet guidelines respectively. Mean dialysis nonadherence score was the lowest (M = 1.3, 
SD = 0.6), followed by medication (M = 1.6, SD = 0.8) and diet (M = 2.2, SD = 0.9) 
(Table 10). 
The percentages of patients reporting intentionally and unintentionally deviating 
from guidelines regarding dialysis exchanges/schedule, medication and diet (“never”, 
“rarely”, “sometimes”, “often” or “very often”) are shown in Figure 9.  
Nonadherence was defined as at least rarely deviating from treatment guidelines. 
According to this criterion, 28%, 58% and 81% of the patients were classified as 
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intentional nonadherent to dialysis, medication and diet, whereas 19%, 71% and 73% 
were classified as unintentional nonadherent to dialysis, medication and diet, respectively. 
Wilcoxon signed-rank tests showed that patients reported more intentional (Mdn = 
1.0) than unintentional (Mdn = 1.0) nonadherence to dialysis, z = 3.07, p = .002; patients 
also reported more intentional (Mdn = 3.0) than unintentional (Mdn = 2.0) nonadherence 
to diet, z = 3.48, p < .001; no significant difference was found between intentional (Mdn 
= 2.0) and unintentional (Mdn = 2.0) nonadherence to medication, z = 1.73, p = .08.  
Mann-Whitney tests showed that APD and CAPD patients reported similar 
nonadherence levels (overall, intentional or unintentional) in all three domains (Table 10). 
These results were confirmed by ANCOVA tests after controlling for covariates. 
χ2 test indicated that a significantly higher percentage of CAPD patients (23%) 
reported shortening treatment sessions when compared with APD patients (2%), χ2(1, N = 


















































Figure 8. Distribution of all patients’ frequencies of overall deviation from different 














Figure 9. Distribution all patients’ frequencies of intentional and unintentional deviation 
from different aspects of the therapeutic regimen.  
































Table 10: Self-reported Nonadherence Outcomes in APD and CAPD Patients 
Self-reported Nonadherence Results in APD and CAPD Patients 
 
Total 
(n = 144) 
APD 
(n = 58) 
CAPD 
(n = 86) 
pa 
Overall nonadherence     
  Dialysis 1.3 ± 0.6  1.2 ± 0.6  1.3 ± 0.6 .76 
  Medication 1.6 ± 0.8  1.7 ± 0.8  1.6 ± 0.8  .14 
  Dietb 2.2 ± 0.9  2.4 ± 0.9  2.2 ± 0.9  .27 
Intentional nonadherence     
  Dialysis 1.4 ± 0.8  1.3 ± 0.6  1.5 ± 0.8  .07 
  Medication 2.0 ± 1.0  2.0 ± 1.0  2.0 ± 1.1  .72 
  Dietc 2.6 ± 1.1  2.7 ± 1.1  2.6 ± 1.1  .58 
Unintentional nonadherence      
  Dialysis 1.2 ± 0.5  1.2 ± 0.4  1.2 ± 0.5  .91 
  Medication 2.1 ± 0.9  2.2 ± 0.9  2.0 ± 0.9  .20 
  Dietb 2.4 ± 1.1  2.5 ± 1.1  2.3 ± 1.1  .32 
Skipping PD sessions 13 (9) 3 (5) 10 (12) .24 
Shortening PD sessions 21 (15) 1 (2) 20 (23) < .001 
Note. Data expressed as M ± SD or n (%). Higher value indicates more nonadherence. 
APD = Automated Peritoneal Dialysis. CAPD = Continuous Ambulatory Peritoneal 
Dialysis. 
aMann-Whitney or χ2 test. bn = 132 because 12 patients reported no dietary restrictions. cn 
= 131 because 12 patients reported no dietary restrictions and one did not answer this 
question. 
 
Nonadherence Based on Biochemical Markers 
Three biochemical markers, potassium, phosphate and albumin, were used to 
assess clinical nonadherence in this study. Table 11 includes reference values for the 
three biochemical markers, their clinical meanings and nonadherence rates (i.e. 
percentages of patients with values outside these targets).  
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Twenty seven (19%) patients had potassium level < 3.5 mmol/l, indicating 
nonadherence to diet. This might also reflect nonadherence to the prescribed medication 
as n = 20 out of the 27 low in potassium patients were prescribed with potassium 
supplements.  
Forty eight (33%) patients had phosphate level > 1.78 mmol/l, which reflects a 
combination of poor adherence to diet and phosphate binders. Based on medical records, 
all respondents but one were prescribed with phosphate binders.   
One hundred and twenty seven (88%) patients did not achieve target albumin 
levels. Low albumin reflects poor nutritional status, suggesting that most patients were 
not eating appropriately.  
Table 11: Nonadherence Based on Biochemical Markers in APD and CAPD Patients 
Nonadherence Based on Biochemical Markers in APD and CAPD Patients 
 
Target levels 
Out-target values signify 
NA to… 
NA, n (%)  
 Total APD CAPD p 
Potassium ≥ 3.5 mmol/l dietary guidelines/ 
potassium supplements 
27 (19) 12 (21) 15 (17) .67 
Phosphate ≤ 1.78mmol/l dietary guidelines/ 
phosphate binders 
48 (33) 23 (40) 25 (29) .21 
Albumin ≥ 3.5 g/dl dietary guidelines 127 (88) 50 (86) 77 (90) .60 
Note. APD = Automated Peritoneal Dialysis. CAPD = Continuous Ambulatory Peritoneal 
Dialysis. NA = nonadherence. 
 
Nonadherence rates based on biochemical markers were equivalent between APD 
and CAPD patients (see Table 11). Interestingly, n = 12 patients reported that they were 
not given any dietary recommendations as part of their treatment. There were however no 
differences in biochemical levels/outcomes (i.e., potassium, phosphate and albumin) 
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between this group and the group of patients who reported having been given dietary 
recommendations.  
Factors Associated With Self-reported Nonadherence 
Univariate Analyses 
Self-reported nonadherence comparison between different subgroups. Kruskal–
Wallis and Mann-Whitney tests were used to compare nonadherence levels in subgroups 
with different demographical and clinical profiles (gender, marital status, ethnicity, 
educational level, employment status, housing, time on dialysis, dependence on carer and 
primary cause of ESRD).   
Results indicated significant differences for ethnicity, employment status, 
education, time on dialysis and primary cause of ESRD (Table 12).   
The Chinese were less likely to forget taking medications (Mdn = 2.0) than non-
Chinese (Mdn = 3.0), U = 1689.0, p = .04.  
Employed patients (Mdn = 3.0) were significantly more likely to intentionally 
deviate from their dietary demands than unemployed patients (Mdn = 2.5), U = 1259.5, p 
= .05.  
Three nonadherence measures, namely intentional nonadherence to medication 
and diet and unintentional nonadherence to medication, varied with education level (H[2] 
= 11.24, p = .003; H[2] = 6.59, p = .04; H[2] = 6.84, p = .03, respectively). Bonferroni-
corrected Mann-Whitney tests (adjusted α = .05/3 = .017) followed up the results and 
revealed that patients with intermediate education showed more both intentional and 
unintentional nonadherence to medication than patients with low education (U = 994.5, p 
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= .002; U = 1089.0, p = .017, respectively), whereas patients with high education only 
showed more intentional nonadherence to medication than patients with low education (U 
= 669.0, p =. 007).  
Time on dialysis had significant impact on intentional nonadherence to dialysis, 
H(2) = 8.58, p = .01. When this was followed up by Bonferroni-corrected Mann-Whitney 
tests (adjusted α = .05/3 = .017), both patients on dialysis for more than two years and 
patients on dialysis between one to two years were found to be significantly more likely 
to intentionally violate their dialysis guidelines (U = 1143.0, p = .015; U = 205.5, p 
= .004 respectively) relative to patients who had been on PD for less than one year. 
Primary cause of ESRD was closely linked with intentional nonadherence to 
medication and diet (H[3] = 12.78, p = .005; H[3] = 15.63, p = .001, respectively). 
Bonferroni-corrected Mann-Whitney tests (adjusted α = .05/6 = .008) were used to make 
pairwise comparisons. Patients with other cause of ESRD were significantly more likely 
to be intentionally nonadherent to medication and dietary guidelines than patients with 
hypertension as primary cause of ESRD (U = 96.5, p = .001; U = 61.0, p = .001 
respectively) and patients with diabetes as primary cause of ESRD (U = 281.5, p = .005; 
U = 190.5, p = .003 respectively). In addition, patients with glomerulonephritis as 
primary cause of ESRD showed significantly more intentional nonadherence to dietary  
guidelines than patients with hypertension as primary cause of ESRD (U = 261.0, p  
 




Table 12: Comparisons of Self- reported Nonadherence Between Different Subgroups 
Comparisons of Self-reported Nonadherence Between Different Subgroups 
Dependent variables 
(n = 144) Factors n 
NA score,  
M ± SD p 
Intentional NA to  Time on dialysis    
dialysis   Less than 1 year 32 1.1 ± 0.4 .01a 
   1 to 2 years 20 1.6 ± 0.9  
   More than 2 years 92 1.5 ± 0.8  
Intentional NA to  Education Level  
medication    Low 54 1.6 ± 1.0 .003a 
   Intermediate 54 2.1 ± 1.0  
   High 36 2.2 ± 1.1  




   Diabetes 62 1.9 ± 1.0 .005a 
   Hypertension 28 1.6  ± 0.8  
   Glomerulonephritis     38 2.2  ± 1.1  
   Other 16 2.6  ± 1.0  
Unintentional NA to  Ethnicity   
medication     Chinese 102 2.0 ± 0.8 .04b 
   Non-Chinese 42 2.4 ± 1.1  
 Education Level    
   Low 54 1.9 ± 0.9 .03a 
   Intermediate 54 2.3 ± 0.9  
   High 36 2.2 ± 0.8  
Intentional NA to  Employment status    
dietc   Employed 33 2.9 ± 0.9 .05b 
   Unemployed 98 2.6 ± 1.1  
 Education Level    
   Low 49 2.3 ± 1.1 .04a 
   Intermediate 51 2.8 ± 1.1  
   High 31 2.9 ± 1.1  




   Diabetes 58 2.5 ± 1.2 .001a 
   Hypertension 26 2.2  ± 1.0  
   Glomerulonephritis     34 2.9  ± 1.0  
   Other 13 3.5  ± 0.8  
Note. APD = Automated Peritoneal Dialysis. CAPD = Continuous Ambulatory Peritoneal 
Dialysis. NA = nonadherence. ESRD = end stage renal disease. 
aKruskal–Wallis test. bMann-Whitney test. cn = 131 because 12 patients reported no 




Correlates of self-reported nonadherence measures. Spearman rank correlation 
coefficients were calculated to investigate the influence of continuous variables (age, pill 
burden, CCI, biochemical marker values, BMQ, self-efficacy, HADS anxiety and 
depression , UCLA loneliness, KDQOL-SF and WHOQOL-BREF scores) on self-
reported nonadherence measures. Significant correlates of self-reported nonadherence 
measures are presented in Table 13.                 
Older age was associated with less nonadherence as indexed by inverse 
associations with unintentional nonadherence to medication and diet (rs = −.29, p < .001;  
rs = −.19, p = .03, respectively) and intentional dietary nonadherence (rs = −.24, p = .007). 
Comorbidity (assessed with CCI) was associated with less nonadherence in some 
domains (see Table 13).  
Patients’ cognitions were significantly associated with nonadherence in the 
expected direction. Strong necessity beliefs were associate with less intentional 
nonadherence to medication (rs = −.19, p = .03), whereas higher concern beliefs were 
associated with nonadherence on almost all measures (all ps < .05; see Table 13 for full 
results). Higher self-efficacy scores were associated with less nonadherence in most 
domains as indexed with inverse correlation with nonadherence scores ( see Table 13).  
Emotional distress (greater symptoms of depression or anxiety) increased 
nonadherence. Quality of life levels (as measured with KDQOL-SF symptoms, effects of 
kidney disease and patient satisfaction, WHOQOL-BREF environment) were also 
significantly associated with nonadherence measures (significant rs ranging from −.17 to 
−32, all ps < ,05, see Table 13 for full results); the overall pattern of results showed that 
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better quality of life was associated with less nonadherence to treatment 
recommendations.  
Table 13: Correlates of Self-reported Nonadherence in Spearman Rank Correlations  
Spearman Rank Correlations Between Self-reported Nonadherence and Selected 
Variables  
            Intentional NA         Unintentional NA 
 Dialysis Medication Diet Dialysis Medication Diet 
Age −.16 −.14 −.24** −.13 −.29*** −.19* 
CCI −.08 −.13 −.20* −.09 −.19* −.16 
BMQ       
  Necessity −.06 −.19* −.06 −.04 −.15 −.08 
  Concerns −.20* −.30*** −.27** −.16 -.21* −.38*** 
Self-efficacy       
  Dialysis −.19* −.16 −.07 −.08 −.25** −.20* 
  Medication −.12 −.35*** −.27** −.04 −.32*** −.40*** 
  Diet −.13 −.37*** −.38*** −.14 −.26** −.52*** 
HADS       
  Anxiety −.12 −.21* −.23** −.12 -.16 −.32*** 
  Depression −.12 −.20* −.16 −.10 -.11 −.21* 
KDQOL-SF       
  Symptoms −.28** −.18* −.12 −.19* −.14 −.14 
  Effects of kidney   t    
  disease 
−.17* −.19* −.18* −.17* −.08 −.21* 
  Patient satisfaction −.32*** −.16 −.10 −.26** −.18* −.26** 
WHOQOL-BREF       
  Environment −.30*** −.16 −.18* −.28** −.16 −.25** 
Note. Spearman rank correlation. NA = nonadherence. CCI = Charlson Comorbidity 
Index. BMQ = Beliefs about Medicines Questionnaire. HADS = Hospital Anxiety and 
Depression Scale. KDQOL-SF = Kidney Disease Quality of Life–Short Form. 
WHOQOL-BREF = World Health Organization Quality of Life Instrument, Short Form.  





Six hierarchical stepwise multiple linear regressions were performed to identify 
important demographical, clinical and psychosocial multivariate correlates of self-
reported intentional and unintentional nonadherence to different aspects of therapeutic 
regimen (dialysis intentional and unintentional, medication intentional and unintentional 
and diet intentional and unintentional). Only variables associated with self-reported 
nonadherence measures in univariate analyses were included in the models. In all 
regression analyses, demographics (age, ethnicity, education level and employment status) 
were entered on the first step, followed by medical variables (modality, time on dialysis, 
CCI and primary cause of ESRD) on the second step and psychosocial variables (BMQ 
necessity and concerns, self-efficacy scores, HADS depression and anxiety scores, 
KDQOL-SF symptoms, effects of kidney disease, patient satisfaction and WHOQOL-
BREF environment) on the final step. Categorical variables were coded as dummy 
variables as appropriate. If one dummy variable was selected by the regression model, all 
related dummy variables were kept in the final model. Forward selection method was 
used for entry of variable into respective blocks. The problem of multicollinearity (strong 
linear relationship among two or more predictors in regression model) was assessed with 
the Variance Inflation Factor (VIF) value. VIF value more than 10 indicates 
multicollinearity (Myers, 1990). VIF values in the current study varied from 1.00 to 2.79, 
indicating no multicollinearity problem. 
The final regression models explained low to moderate proportions of variance in 
self-report nonadherence scores (cumulative R2 = .11 to .31). Psychosocial variables (ΔR2 
= .07 to .31) independently accounted for more variance in self-reported nonadherence 
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scores relative to demographical (ΔR2 = .00 to .09) and clinical variables (ΔR2 = .00 to .08) 
(see Table 14 to Table 16)  
Intentional nonadherence to dialysis exchanges. Education, modality, KDQOL-
SF patients satisfaction and WHOQOL-BREF environment were significant predictors of 
intentional nonadherence to dialysis exchanges in the final regression model, accounting 
for R2 = .19, R2adj = .16 of the variance, F(5, 138) = 6.32, p < .001. High education (vs. 
low education) (β = .22, p = .01, ΔR2 = .03) and CAPD (β = .22, p = .006, ΔR2 = .03) 
were positively associated with intentional nonadherence to dialysis guidelines, whereas 
patient satisfaction (β = −.21, p = .02, ΔR2 = .09) and WHOQOL environment (β = −.21, 
p = .02, ΔR2 = .04) were inversely associated with intentional nonadherence to dialysis 
guidelines (Table 14).  
Unintentional nonadherence to dialysis. The final regression model (F[3, 140] = 
5.92, p = .001) explained R2 = .11, R2adj = .09 of the variance in unintentional 
nonadherence to dialysis, with time on dialysis and WHOQOL environment quality of 
life being significant at the final step. More than 2 years on dialysis (vs. less than 1 year) 
(β = .22, p = .02, ΔR2 = .04) and lower environment quality of life score (β = −.27, p 
= .001, ΔR2 = .07) were associated with greater unintentional nonadherence 




Table 14: Multivariate Correlates of Self-reported Nonadherence to Dialysis Guidelines 
Multivariate Correlates of Self-reported Nonadherence to Dialysis Guidelines 
 
Dependent variable: intentional nonadherence to dialysis guidelines 
Step     Predictor     B     β  R2 R2adj ΔR2  ΔF  p 
1     Intermediate education 
    (vs. low education)  
−0.04 −.03 .03 .02 .03 2.48 .09 
     High education 
    (vs. low education) 
−0.39 −.22*   
 
2     CAPD (vs. APD) −0.34 −.22** .06 .05 .03 4.74 .03 
3 KDQOL-SF patient    
satisfaction 
−0.007 −.21* .15 .13 .09 10.23 
< .001
 WHOQOL-BREF    
environment 
−0.06 −.21* .19 .16 .04  
 
 
Dependent variable: unintentional nonadherence to dialysis guidelines 
Step     Predictor     B      β  R2 R2adj ΔR2  ΔF  p 
2     1 to 2 years on dialysis 
    (vs. less than 1year)  
−0.05 −.04 .04 .03 .04 2.89 .06 
 More than 2 years on   
dialysis 
    (vs. less than 1 year)  
−0.21 −.22*     
3 WHOQOL-BREF  
environment 
−0.05 −.27** .11 .09 .07 11.56 .001 
Note.  Hierarchical stepwise multiple linear regressions were used. APD = Automated 
Peritoneal Dialysis. CAPD = Continuous Ambulatory Peritoneal Dialysis. KDQOL-SF = 
Kidney Disease Quality of Life–Short Form. WHOQOL-BREF = World Health 
Organization Quality of Life Instrument, Short Form.  




Intentional nonadherence to medication. In the final regression model, three 
variables, namely primary cause of ESRD, medication self-efficacy and BMQ concerns, 
emerged as significant multivariate correlates of intentional nonadherence to medication, 
explaining R2 = .24, R2adj =.21of the variance, F(5, 138) = 8.55, p < .001 (Table 15). 
Diabetes (β = −.38, p = .003, ΔR2 = .01) and hypertension (β = −.30, p = .008, ΔR2 = .06) 
as primary causes of ESRD (vs. other cause of ESRD), as well as medication self-
efficacy (β = −.32, p < .001, ΔR2 = .13) were negatively associated with intentional 
nonadherence to medication. Concern beliefs (β = .19, p = .02, ΔR2 = .03) were positively 
correlated with intentional nonadherence to medication. 
Unintentional nonadherence to medication. Two demographic variables (age and 
ethnicity) and one psychosocial factor (medication self-efficacy) remained significant in 
predicting unintentional nonadherence to medication (i.e., medication forgetfulness) at 
the final step of the regression, F(3, 140) = 9.58, p < .001, R2 = .17. R2adj = .15 (Table 15). 
All of them were negatively correlated with unintentional nonadherence to medication 
(age β = −.20, p = .01, ΔR2 = .05; Chinese β = −.18, p = .02, ΔR2 = .04; self-efficacy β = 
−.28, p < .001, ΔR2 = .08). 
Intentional nonadherence to dietary guidelines. The final regression model only 
included age and dietary self-efficacy, F(2, 128) = 12.83, p < .001, R2 = .17, R2adj = .15 
(Table 16). Both age (β = −.18, p = .03, ΔR2 = .04) and dietary self-efficacy (β = −.36, p = 
<.001, ΔR2 = .13) were inversely correlated with intentional nonadherence to dietary 





Table 15: Multivariate Correlates of Self-reported Nonadherence to Medication Guidelines 
Multivariate Correlates of Self-reported Nonadherence to Medication Guidelines 
 
Dependent variable: intentional nonadherence to medication guidelines 
 
Step     Predictor      B      β  R2 R2adj ΔR2   ΔF  p 
2   Diabetes as primary   
  cause of ESRD 
  (vs. other causes) 
−0.79 −.38** .08 .06 .08 4.20 .007 
 Hypertension as primary  
    cause of ESRD 
  (vs. other causes) 
-0.80 −.30**      
     GN as primary cause of    
    ESRD 
    (vs. other causes) 
−0.39 −.17     
 
3     Medication SE  −0.17 −.32*** .21 .18 .13 13.92 < .001
     BMQ concerns  −0.04 −.19* .24 .21 .03   
 
Dependent variable: unintentional nonadherence to medication guidelines 
 
Step     Predictor       B     β  R2 R2adj ΔR2  ΔF p 
1     Age   −0.01 −.20* .05 .05 .05 7.04 .001 
 Chinese  
(vs. non-Chinese) 
  −0.36 −.18* .09 .08 .04  
 
3     Medication SE   −0.13 −.28*** .17 .15 .08 13.42 < .001
Note. Hierarchical stepwise multiple linear regressions were used. ESRD = End Stage 
Renal Disease.GN = Glomerulonephritis. SE = self-efficacy. BMQ = Beliefs about 
Medicines Questionnaire.  





 Unintentional nonadherence to dietary guidelines. Only two psychosocial factors 
(dietary self-efficacy and BMQ concerns) were significant in predicting unintentional 
nonadherence to diet at the final step of the regression model, F(2, 129) = 28.63, p < .001, 
R2 = .31, R2adj = .30 (Table 16). Dietary self-efficacy (β = −.43, p < .001, ΔR2 = .26) was 
negatively correlated with unintentional nonadherence to diet, whereas BMQ concerns (β 
= .24, p = .003, ΔR2 = .05) were positively correlated with unintentional nonadherence to 
diet.  
Table 16:  
Multivariate Correlates of Self-reported Nonadherence to Dietary Guidelines 
 
Dependent variable: intentional nonadherence to dietary guidelines 
 
Step     Predictor     B      β  R2 R2adj ΔR2 ΔF  p 
1     Age −0.02   −.18* .04 .03 .04 4.71 .03 
3     Dietary SE −0.19   −.36*** .17 .15 .13 20.25 < .001
 
Dependent variable: unintentional nonadherence to dietary guidelines 
 
Step     Predictor     B    β  R2 R2adj ΔR2   ΔF  p 
3     Dietary SE −0.22 −.43*** .26 .25 .26 28.63 < .001
     BMQ concerns −0.05 −.24** .31 .30 .05   
Note. Hierarchical stepwise multiple linear regressions were used. SE = self-efficacy. 
BMQ = Beliefs about Medicines Questionnaire. 




As can be seen in Table 13, intentional nonadherence to medication was 
significantly correlated with anxiety and depression. These two relationships remained 
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significant after adjusting for covariate (i.e., primary cause of ESRD, see Table 15) in 
regression analyses (β = .22, p = .008 for anxiety; β = .20, p = .02 for depression, data not 
shown). In addition, both depression and anxiety were significantly correlated with 
concern beliefs and medication self-efficacy (Table 17) which were significantly 
associated with intentional nonadherence to medication in multivariate analysis after 
adjusting for covariates (Table 15). Thus there was indication of mediation based on the 
suggestions of Barron and Kenny (1986). In order to formally test the mediation effects, 
we built two hypothesized models. One used anxiety as the predictor (Figure 10) and the 
other one used depression as the predictor (Figure 11). Both models used concern beliefs 
and medication self-efficacy as mediators simultaneously. These two models were tested 
with the aforementioned SPSS macro provided by Preacher and Hayes (2008).  
        Table 17: Correlation Between Emotional Distress and Health Beliefs 
        Spearman Rank Correlations Between Emotional Distress and Health Beliefs  
 Anxiety Depression 
BMQ concerns −.43*** −.41*** 
Medication SE −.28** −.24** 
Dialysis SE −.42*** −.36*** 
        Note. SE = Self-efficacy. 
            **p < .01.  ***p < .001   
  
The total effect (i.e., the influence of the predictor to the dependent variable before 
controlling for mediators) of anxiety on intentional nonadherence to medication (total 
effect = .05, p = .008) became nonsignificant after entering health belief mediators into 
the model, direct effect (i.e., the influence of the predictor to the dependent variable after 






(i.e., total effect minus direct effect; it evaluates the influence of the predictor to the 
dependent variable via the mediator) of medication self-efficacy = [.006, .037]. Since 
zero was not included in this interval, it indicated that self-efficacy was a significant 
mediator. Although the association between concern beliefs and intentional nonadherence 
to medication was only marginally significant (p = .06), concern beliefs were also a 
significant mediator based on the bootstrapping outcome (indirect effect 95% CI = 
[.0007, .032]). Thus self-efficacy and concern beliefs together totally mediated the  











Figure 10. Health belief mediators of the relationship between anxiety and intentional 
nonadherence to medication.  
Note. SE = self-efficacy. NA = nonadherence. BMQ = Beliefs about Medicines 
Questionnaire. Path values represent unstandardized regression coefficients. For the 
direct path from anxiety to nonadherence, the value outside of the parentheses represents 
the unstandardized regression coefficient before adding the health belief mediators into 
the model (total effect). The value inside of the parentheses represents the unstandardized 
regression coefficient after entering the health belief mediators into the model (direct 
effect).  
* p < .05. ** p < .01. *** p < .001.   
 
Similarly, the total effect of depression on intentional nonadherence to medication 
(total effect = .04, p = .02) became nonsignificant after entering health belief mediators 
into the model (direct effect = .01, p = .49, Figure 11). The indirect effects of both 
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medication self-efficacy and concern beliefs were significant, with 95% CIs = 
[.006, .033] and [.0008, .035] respectively. Thus medication self-efficacy and concern 
beliefs together also totally mediated the relationship between depression and intentional 











Figure 11. Health belief mediators of the relationship between depression and intentional 
nonadherence to medication. 
Note. SE = self-efficacy. NA = nonadherence. BMQ = Beliefs about Medicines 
Questionnaire. Path values represent unstandardized regression coefficients. For the 
direct path from depression to nonadherence, the value outside of the parentheses 
represents the unstandardized regression coefficient before adding the health belief 
mediators into the model (total effect). The value inside of the parentheses represents the 
unstandardized regression coefficient after entering the health belief mediators into the 
model (direct effect).  
* p < .05. ** p < .01. *** p < .001.   
 
Using similar steps as mentioned above, we found out that dietary self-efficacy and 
concern beliefs together also totally mediated the relationship between anxiety and 
unintentional nonadherence to diet (total effect = .06, p = .001; direct effect = .004, p 
= .85); indirect effect 95% CIs = [.019, .064] and [.004, .039] for dietary self-efficacy and 
concern beliefs respectively, Figure 12) as well as the relationship between depression 
and unintentional nonadherence to diet (total effect = .05, p = .02; direct effect = −.02, p 
= .43; indirect effect 95% CIs = [.020, .070] and [.006, .047] for dietary self-efficacy and 
Depression 
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concern beliefs respectively, Figure 13). In addition, dietary self-efficacy alone mediated 
the relationship between anxiety and intentional nonadherence to diet after controlling for 
covariate (i.e., age, see Table16). Total effect = .05, p = .02; direct effect = .01, p = .47; 











Figure 12. Health belief mediators of the relationship between anxiety and unintentional 
nonadherence to diet. 
Note. SE = self-efficacy. NA = nonadherence. BMQ = Beliefs about Medicines 
Questionnaire. Path values represent unstandardized regression coefficients. For the 
direct path from anxiety to nonadherence, the value outside of the parentheses represents 
the unstandardized regression coefficient before adding the health belief mediators into 
the model (total effect). The value inside of the parentheses represents the unstandardized 
regression coefficient after entering the health belief mediators into the model (direct 
effect).  
























Figure 13. Health belief mediators of the relationship between depression and 
unintentional nonadherence to diet. 
Note. SE = self-efficacy. NA = nonadherence. BMQ = Beliefs about Medicines 
Questionnaire. Path values represent unstandardized regression coefficients. For the 
direct path from depression to nonadherence, the value outside of the parentheses 
represents the unstandardized regression coefficient before adding the health belief 
mediators into the model (total effect). The value inside of the parentheses represents the 
unstandardized regression coefficient after entering the health belief mediators into the 
model (direct effect).  









Figure 14. Health belief mediator of the relationship between anxiety and intentional 
nonadherence to diet. 
Note. SE = self-efficacy. NA = nonadherence. Path values represent unstandardized 
regression coefficients. For the direct path from anxiety to nonadherence, the value 
outside of the parentheses represents the unstandardized regression coefficient before 
adding the health belief mediators into the model (total effect). The value inside of the 
parentheses represents the unstandardized regression coefficient after entering the health 
belief mediators into the model (direct effect).  













Factors Associated With Nonadherence Based on Biochemical Markers 
Univariate Analyses 
Demographical, clinical and psychosocial factors associated with potassium, 
phosphate and albumin levels (as binary data) in univariate analyses (t tests, Mann-
Whitney, χ2 or Fisher’s exact tests as appropriate for each type of variable) are listed in 
Table 18. Significant associations were mainly found for demographic and clinical 
variables albeit not consistent across biochemical markers (Table 18). SF-12 MCS was 
the only psychosocial factor affecting nonadherence based on biochemical markers in 
univariate analyses. 
Patients nonadherent to potassium (< 3.5 mmol/l) were significantly more likely 
to be dependent on carers (χ2[1, N = 144] = 4.39, p = .05), having higher level of pill 
burden (Mann-Whitney U = 1144.0, p = .02) and more comorbidity (Mann-Whitney U = 
1087.5, p = .01).  
Patients nonadherent to phosphate (> 1.78 mmol/l) were significantly more likely 
to be younger (Mann-Whitney U = 1400.0, p < .001), female (χ2[1, N = 144] = 7.49, p  
= .007), employed (χ2[1, N = 144] = 6.45, p = .02), and having less comorbidity (Mann-
Whitney U = 1650.0, p = .005).  
Patients nonadherent to albumin (< 3.5 g/dl) were significantly more likely to be 
older (Mann-Whitney U = 705.0, p = .02), unemployed (Fisher’s exact test, p = .02), 
living in poorer housing conditions (Fisher’s exact test, p = .01), having more 
comorbidity (Mann-Whitney U = 680.5, p = .01), worse physical quality of life (SF-12 
PCS t[142] = −2.13, p = .04) and worse mental quality of life (SF-12 MCS Mann-
Whitney U = 740.0, p = .04). 
82 
 
Table 18: Factors Affecting Nonadherence Based on Biochemical Markers in Univariate Analyses 
Factors Affecting Nonadherence Based on Biochemical Markers in Univariate Analyses 
 Adherent Nonadherent p 
 Potassium  
≥ 3.5 mmol/l 
(n = 117) 
Potassium  
< 3.5 mmol/l 
(n = 27) 
 
Dependence on carer,  25 (21) 11 (41)       .05 
Pill purden 10.1 ± 2.7 11.1 ± 1.8       .02a 
CCI 5.4 ± 2.0 6.4 ± 1.9       .01a 
 Phosphate 
≤ 1.78 mmol/l 
(n = 96) 
Phosphate  
> 1.78 mmol/l 
(n = 48) 
 
Age 60.8 ± 12.0 52.4 ± 13.0      < .001a
Male 49 (51) 13 (27)       .007 
Employed 19 (20) 19 (40)       .02 




≥ 3.5 g/dl 
(n = 17) 
Albumin  
< 3.5g/dl 
(n = 127) 
 
Age 48.5 ± 17.6 59.3 ± 11.7       .02a 
Employed 9 (53) 29 (23)       .02b 
Housing condition    
   1−4 rooms flats  5 (29) 83 (65)       .01b 
   5-rooms flats 7 (42) 28 (22)  
   Condominum or above 5 (29) 16 (13)  
CCI 4.4 ± 2.1 5.7 ± 1.9       .01a 
SF-12 PCS 40.1 ± 11.1 35.1 ± 8.8 .04 
SF-12 MCS 48.4 ± 8.8 43.0 ± 11.2 .04a 
Note. Data expressed as M ± SD or n (%). ESRD = End Stage Renal Disease. CCI = 
Charlson Comorbidity Index. SF-12 = 12-item Short-Form Health Survey. PCS = 
physical component summary score. MCS = mental component summary score.  




Clinical nonadherence indices (based on potassium, phosphate and albumin 
clinical targets) were subsequently regressed to demographic, clinical and psychosocial 
variables in three separate hierarchical stepwise logistic regression models. Only 
variables associated with nonadherence based on biochemical markers in univariate 
analyses (reported earlier) were entered as potential predictors. In all regression analyses, 
demographics (age, gender, employment status and housing condition) were entered on 
the first step, followed by medical variables (dependence on carer, pill burden and CCI) 
on the second step and psychosocial variables (SF-12 PCS and SF-12 MCS) on the final 
step. Nagelkerke R2, similar to R2 in linear regression, was calculated to assess how much 
variance in nonadherence (based on biochemical markers) could be explained by the 
regression models. Forward: likelihood ratio method was used for variable selection.  
Table 19 presents the final regression models.   
Potassium < 3.5 mmol/l. The only variable that was significant in predicting 
potassium < 3.5 mmol/l at the final step of the logistic regression was CCI, accounting 
for Nagelkerke R2 = .07 of the variance (Omnibus χ2[1, N = 144] = 6.05, p = .01). One 
score increment on CCI was associated with 30% more likelihood of potassium < 3.5 
mmol/l (OR = 1.30, 95% CI = [1.05, 1.62], p = .02). This model correctly classified 
potassium status in 81% of the cases.   
Phosphate > 1.78 mmol/l. Only age and gender were significant in predicting 
phosphate > 1.78 mmol/l at the final step of the logistic regression, accounting for 
Nagelkerke R2 = .18 of the variance, Omnibus χ2(2, N = 144) = 19.63, p < .001. One year 
increment of age was associated with 5% less likelihood of phosphate > 1.78 mmol/l (OR 
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= 0.95, 95% CI = [0.92, 0.98], p = .001). Female was 1.5 times more likely than men to 
have phosphate > 1.78 mmol/l (OR = 2.53, 95% CI = [1.15, 5.55], p = .02). The final 
model correctly classified phosphate status in 70% of the cases.   
Albumin < 3.5 g/dl. Albumin level < 3.5 g/dl was explained by age and housing 
condition, Omnibus χ2(3, N = 144) = 20.87, p < .001, Nagelkerke R2 = .26. One increment 
on age increased the likelihood of albumin < 3.5 g/dl by 8% (OR = 1.08, 95% CI = [1.03, 
1.12], p = .001). Patients living in 5-rooms flats and Condominiums or above were 85% 
less likely to have albumin level < 3.5 g/dl when compared to patients living in 1-4 rooms 
flats (OR = 0.15, 95% CI = [0.04, 0.57], p = .006; OR = 0.15, 95% CI = [0.03, 0.65], p 





Table 19: Predictors of Nonadherence Based on Biochemical Markers in Multivariate Analyses 
Factors Affecting Nonadherence Based on Biochemical Markers in Multivariate Analyses 
 
Dependent variable: potassium < 3.5 mmol/l 
 
Step     Predictor      B OR Nagelkerke R2   χ2 p 
2 CCI −.26* 1.30 .07 6.05 .01 
 
Dependent variable: phosphate > 1.78 mmol/l 
 
Step     Predictor      B  OR Nagelkerke R2    χ2 p 
1     Age −0.05** 0.95 .13 19.63 < .001 
     Female (vs. male) −0.93* 2.53 .18   
 
Dependent variable: albumin < 3.5 g/dl 
 
Step    Predictor     B OR Nagelkerke R2    χ2 p 
1     Age −0.07** 1.08 .13 20.87 <.001 
    5 rooms flats 
(vs. 1−4 rooms flats) 
−1.91** 0.15 .26   
     Condominiums and above  
(vs. 1−4 rooms flats)    
−1.91* 0.15    
Note. Hierarchical stepwise logistic regressions were used. OR = Odds Ratio. CCI = 
Charlson Comorbidity Index.  










This is the first systematic study conducted to examine the prevalence and 
predictors of intentional and unintentional nonadherence in a group of APD and CAPD 
patients. Patients perceived taking medication to be highly necessary, but were concerned 
about their effects. Self-efficacy belief was highest for dialysis exchanges, followed by 
medication and diet. Our data indicated high rates of depression, anxiety and loneliness. 
Quality of life was found to be compromised relative to general populations, but 
impairment was more pronounced in physical than mental well-being. Both intentional 
and unintentional nonadherence rates were high in this sample. Nonadherence was 
mainly related with patients’ beliefs and quality of life whereas emotional distress was 
indirectly related to nonadherence,  
This chapter discusses the stated findings. It is organized into eight sections: 
section one focuses on patients’ beliefs; section two discusses emotional distress; section 
three focuses on quality of life; sections four and five discusses prevalence and  
determinants of nonadherence and the final three sections are about clinical 
recommendations, study strengths and limitations, and future directions. 
Health Beliefs  
Patients in our study expressed strong beliefs that that medication intake was 
necessary to manage their disease, but remained moderately concerned about the 
potential harms caused by the medication. Based on the necessity-concerns differential, 
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73% of the patients perceived a higher level of necessity than concerns about the effects 
of their prescribed medication. However, the concerns score was significantly higher 
(indicating more concerns) than reported in patients with renal disease or other chronic 
illness conditions in other studies (Horne & Weinman, 1999; Rees et al., 2010). This, on 
one hand, suggests that the patients were well-informed about the relative importance of 
taking the medication but on the other hand, they were somehow worried about drug 
dependence/side effects. This higher-than-usual concern beliefs may be related to 
experience or a lack of education on the effects of medication. There is ample evidence 
that patients have limited awareness/understanding about their medication (Pakpour et al., 
2010; Sayin et al., 2007). In a study about drug knowledge in the elderly, 60% of the 
patients knew the purpose of treatment, 21% knew the consequences of omission, but less 
than 5% possessed the knowledge about drug side effects, toxic risks and possible 
interactions between drugs (Barat, Andreasen, & Damsgaard, 2001).  
Our study measured generic self-efficacy as well as self-efficacy to three main 
components of the therapeutic regimen for PD, namely dialysis, medication and diet. 
Generic self-efficacy was comparable to a study in China (Su, Lu, Chen, & Wang, 2009). 
Since we used our own self-efficacy measures for dialysis, medication and diet, there was 
no basis for comparison with other studies. Dialysis self-efficacy was found to be higher 
than medication and dietary self-efficacy. This is not unexpected. PD patients go through 
extensive training regarding how to perform PD exchanges well before they begin to use 
this modality daily. It is very likely that dialysis self-efficacy is strengthened by patients’ 
successful experience during this period, since mastery experience, especially when it 
occurs in the early stages of a task, is the most important source of self-efficacy (Bandura, 
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1977). Support mechanisms/programs are currently in place within hospital (SGH) to 
support patients in performing dialysis exchanges at home environment (including home 
visits by PD nurses and 24 hours helpline) once in-hospital training is completed, which 
may further enhance self-efficacy for performance of dialysis exchanges.  
Health Beliefs Comparison Between APD and CAPD Patients 
CAPD patients reported more self-efficacy about taking medication than APD 
patients and this difference remained significant after accounting for case-mix differences. 
One possible explanation for the observed difference is that CAPD patients may be more 
likely to be regularly reminded of aspects related to medical management as their 
treatment involves multiple exchanges in a day. The more intensive regime of four 
exchanges albeit disruptive in daily activities may serve to focus patients on the other 
aspects of medical treatment, namely the intake of medication. It is also likely that 
distraction due to social and work activities in CAPD is limited, as fewer patients are 
working while on CAPD due to regimen routine. Finally, CAPD is performed manually 
and patients can learn it much quicker than APD (Tornay & Sanchez, 2003). This may 
give CAPD patients more confidence which transfers and generalizes into a general 
confidence with other aspects of treatment, namely medication intake. 
Emotional Distress 
The prevalence of possible depression (HADS depression ≥ 8) was 62% which 
was substantial. Even when a more stringent cutoff (HADS depression ≥ 11) was used, 
40% of the patients could still be classified as depressed. Depression rates in different 
studies are subjected to a wide spectrum, with studies citing depression rates that varied 
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from 10% to 70% in PD patients (Atalay et al., 2010; Brown et al., 2010; Conde et al., 
2010; Guney et al., 2010; Ko et al., 2010; Riezebos et al., 2010; Senol et al., 2010) and 
from 23.7% to 45.9% in HD patients (Agganis et al., 2010; Brown et al., 2010; Conde et 
al., 2010; Fernandes et al., 2010; Hung et al., 2011; Jaber et al., 2010; Riezebos et al., 
2010). It is worthwhile to mention that our depression rate (62%) was comparable to the 
rates reported in other Asian nations, ranging from 53.8% to 75% (Kim et al., 2002; Ko et 
al., 2010). 
The prevalence of anxiety (HADS anxiety ≥ 8) was found to be 41%. When a 
more stringent cutoff (HADS anxiety ≥ 11) was implemented, this rate decreased to 26%. 
Rates of anxiety reported in HD studies varied from 27% to 45.7% (Cukor et al., 2007; 
Cukor et al., 2008; Taskapan et al., 2005). Little data is available about the prevalence of 
anxiety in PD patients. A small sample study (n = 30) in Singapore using HADS (cut-off 
value = 8) classified 50% of the CAPD patients as anxious and 13% as depressed (Lye et 
al., 1997). Our anxiety rate was lower than this local study, probably because they used a 
sample with 73% (vs. 6% in our study) of uneducated patients. Low education is 
associated with more uncertainty about the disease, therapy and future (Madar & Bar-Tal, 
2009) and this may contribute to a higher level of anxiety.  
Although our rates of depression (62%) and anxiety (41%) were in line with those 
reported in previous studies on dialysis patients (Cukor et al., 2008; Diefenthaeler et al., 
2008; Hung et al., 2011; Kim et al., 2002; Ko et al., 2010; Senol et al., 2010; Taskapan et 
al., 2005), they are remarkably/alarmingly high when compared with the rates reported in 
community-dwelling elderly which varied from 7.9% to 13.3% for depression and was 
2.6% for anxiety (Broekman et al., 2008; Niti, Ng, Kua, Ho, & Tan, 2007; Yap, Niti, & 
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Ng, 2007). Two local studies evaluated the prevalence of depression in patients with 
chronic obstructive pulmonary disease with HADS (cut-off value = 8) and reported the 
rates to be from 42% to 44% for depression and from 10% to 11% for anxiety (Cao, Ong, 
Eng, Tan, & Ng, 2006; Ng et al., 2007). Thus the prevalence of depression and anxiety is 
substantial in our sample even when compared to other patient populations in Singapore.  
More than half of the patients (57%) in our study reported moderate to high levels 
of loneliness. In contrast, only 15.4% of PD patients in the study of Asti et al. (2006) 
reported loneliness. Their patients scored quite high on perceived social support from 
spouses and friends which was an inverse correlate of loneliness (Kara & Mirici, 2004). 
Depression, anxiety and loneliness are close constructs and can all be responses to social 
exclusion (Leary, 1990). An examination on the individual item scores of the Revised 
UCLA Loneliness Scale identified “My interests and ideas are not shared by those around 
me” and “No one really knows me well” as the top two concerns, highlighting the role of 
lacking understanding from others in patients’ loneliness. This sense of insufficient 
understanding, in part, can be induced by patients’ own withdrawal behaviors, as 
literature suggests that dialysis patients feel shamed about discussing their experiences 
with others and would intentionally withdraw from social activities in order to avoid 
talking about their disease (Herlin & Wann-Hansson, 2010).  
Contextual and cultural factors might explain the poor emotional outcomes in the 
study sample. Firstly, dialysis expenses are not fully covered by Singapore government 
resources (Lai, Lui, & Chan, 1999). Although there are subsidies and charity 
organizations for the financially needy, many patients still have to pay a large amount of 
money. Financial concern was found to be the biggest stressor in Singapore CAPD 
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patients, followed by sexual dysfunction and unemployment (Lye et al., 1997). Secondly, 
PD is in conflict with patients’ desire to hide their chronic disease from neighbors and 
friends because there is stigma attached to physical illnesses, especially in the Asian 
context (Bakewell et al., 2001). The delivery of PD solutions and medicalized housing 
arrangements are very likely to expose patients’ renal disease to their neighbors and 
visitors. This presents an extra burden to the patients. Thirdly, it is common to hire 
domestic workers (or maids) in Singapore. Some elderly whose questionnaires were 
administered at home by a research assistant volunteered without prompting that their 
malaises with maids were very distressing to them. They constantly worried about their 
maids’ capabilities of caring for them and faced the dilemma of being unable to change 
maids when they were not satisfied, since it meant that no one would look after them 
before they could find another maid and that they needed to go through the expensive and 
time-consuming PD training again with their new maids.  
Emotional Distress Comparison Between APD and CAPD Patients 
We found no effect of PD modality on depression and anxiety. Sixty four percent 
of APD and 62% of CAPD patients have possible depression (HADS depression ≥ 8). In 
another study, Guney et al. (2010) used the Beck Depression Inventory and reported 
equal depression levels in the two groups (70% in APD vs. 62.5% in CAPD). In contrast, 
Griva et al. (2010) reported a significantly lower rate of depression in APD (26.1%) than 
CAPD (44.4%) patients. Possible anxiety was also equivalent between the two groups (41% 
APD vs. 41% CAPD) in our study, contradictory to the finding of de Wit et al. (2001) 
that APD patients were less depressed and anxious than CAPD patients. Loneliness score 
further indicated equivalent emotional distress between APD and CAPD groups in our 
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study. Fifty three percent of APD and 59% of CAPD patients reported at least a moderate 
level of loneliness. It is noted that both studies reporting better emotional outcomes in 
APD than CAPD patients (de Wit et al., 2001; Griva et al., 2010) were conducted in 
European countries where patients’ medical expenses are well-covered by public funds 
and cost differences between the two modalities are not a major concern for patients. 
However, in Singapore, the significantly higher financial burden associated with APD 
(Lai et al., 1999) may offset the benefits of less onerous treatment requirements on 
patients’ psychological adjustment. 
Quality of Life 
Both physical and mental quality of life (assessed with the SF-12 PCS and MCS 
scores, respectively) of the current sample were lower relative to the general population 
(Singapore) norms (Thumboo et al., 2001), attesting to the profound negative impact of 
renal disease on physical and emotional well-being. Similar findings have been reported 
in the overwhelming majority of previous studies on PD patients (Maglakelidze et al., 
2011; Osthus et al., 2010; Sayin et al., 2007). This finding may have clinical implications 
as poor quality of life has been found to be independently associated with poorer 
outcomes such as increased mortality and hospitalization rates in PD patients (Lowrie, 
Curtin, LePain, & Schatell, 2003; Mapes et al., 2004; Mapes et al., 2003; Paniagua, 
Amato, Vonesh, Guo, & Mujais, 2005).   
The mean SF-12 MCS score was significantly lower than the mean SF-12 PCS 
score in this study. A greater effect of renal disease on self-assessed physical, compared 
to mental, health has also been found in other studies on dialysis patients (Bohlke et al., 
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2008; Brown et al., 2010; de Wit et al., 2001). It may be the case that the negative impact 
of chronic disease on aspects of mental or emotional well-being becomes ameliorated 
over time as psychological adaptation takes place (Andrykowski & Hunt, 1993), 
consistent with Taylor’s (1983) theory of cognitive adaptation to life-threatening events. 
The mean SF-12 PCS and SF-12 MCS scores in this study were 35.7 (SD = 9.2) 
and 43.6 (SD = 11.0) respectively. The quality of life scores were lower than those 
reported in previous dialysis studies yet not consistently so – some studies reported 
higher MCS and PCS than us (Bohlke et al., 2008; Guney et al., 2010; Ibrahim & El 
Salamony, 2008; Kalender, Ozdemir, Dervisoglu, & Ozdemir, 2007), some higher PCS 
only (Fructuoso et al., 2011; Pakpour et al., 2010; Senol et al., 2010; Thong et al., 2009), 
some higher MCS only (Brown et al., 2010) and some comparable findings (Vasilieva, 
2006). These differences are mainly due to case-mix differences (e.g., age, time on 
dialysis, diabetic status, employment status, education status).  
Two additional factors might explain the worse quality of life outcomes in our 
study than most other studies mentioned above. Firstly, a significantly higher proportion 
of patients were malnourished (indicated by 88% of the patients with albumin level < 3.5 
g/dl) in our study than other studies and nutritional status is a critical determinant of 
quality of life in literature (Bilgic et al., 2008; Chiu et al., 2009). Secondly, most of the 
other studies were conducted in European countries. Asian patients have been found to 
have poorer understanding about their disease than Caucasian patients (Bakewell et al., 
2002) and this may account for feelings of uncertainty and poor quality of life.  
Quality of life levels on the kidney disease specific domains were variable. 
Symptoms and effects of kidney disease were comparable to those reported in previous 
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studies, burden of kidney disease was inconclusive, while patient satisfaction, staff 
encouragement and social support on the other hand were lower than other studies 
(Fructuoso et al., 2011; Molsted, Prescott, Heaf, & Eidemak, 2007; Osthus et al., 2010; 
Wong, Chow, & Chan, 2010). The observed low levels of satisfaction, staff 
encouragement and social support in our study sample seem to suggest that there is room 
for improvement in health care setting and patient-doctor interaction. SGH has the largest 
PD population in all tertiary health care setting/hospitals in Singapore. There are 18 
consultants in the PD center and more than five hundred PD patients. It is likely that there 
may be less opportunities for more intimate care or that the demands on health care 
professions’ time may be too onerous, which lead to consultations that may be perceived 
as unsatisfactory or unsupportive.  
WHOQOL-BREF data revealed that our study sample had lower levels of quality 
of life with physical health, mental health and social relationships but comparable 
environment quality of life when compared with international norms (Skevington et al., 
2004). Other studies also reported reduced opportunities for a rich social life in dialysis 
patients and this was perceived as a top stressor (Gudex, 1995; Herlin & Wann-Hansson, 
2010; Lok, 1996). Decreased social functioning may be due to factors such as physical 
limitations, feeling different, being avoided by healthy individuals, fatigue, the need to 
management regimens, to avoid infections and to hide their disease conditions (Chow & 
Wong, 2010; Miller, 1985).   
WHOQOL-BREF was also used in two other studies, one in Greece (Ginieri-
Coccossis, Theofilou, Synodinou, Tomaras, & Soldatos, 2008) and the other in Taiwan 
(Niu & Li, 2005). Both studies assessed WHOQOL-BREF scores in PD and HD patients. 
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Our results were generally comparable to these two studies, though our patients showed 
better psychological health than the Taiwanese patients. In addition to case-mix 
differences, Taiwan patients might have more emotional distress than our sample due to a 
very low proportion of patients getting transplant annually (0.26% in Taiwan vs. 17% in 
Singapore) (Niu & Li, 2005; Vathsala & Chow, 2009). A local study used WHOQOL-
BREF to evaluate quality of life in subjects with first episode psychosis and these 
subjects scored lower on all four domains than the current study (Sim, Mahendran, Siris, 
Heckers, & Chong, 2004). Thus the quality of life of our patients, although diminished, 
was still better than patients with severe psychiatric disorder.   
Quality of life Comparison Between APD and CAPD 
Our study found comparable quality of life between APD and CAPD patients. 
APD patients reported significantly fewer symptoms than CAPD patients, but this 
difference became negligible after adjusting for covariates. Our study was consistent with 
four previous findings (Balasubramanian et al., 2011; Bro et al., 1999; de Wit et al., 2001; 
Guney et al., 2010) and suggests that PD modality (APD or CAPD) might have only a 
minor influence on patients’ quality of life since, as mentioned above, psychological 
adaptation can occur over time. Diaz-Buxo et al. (2000) reported that APD patients had 
worse physical but better mental quality of life than CAPD patients but the methodology 
of this study is questioned since it did not adjust for critical case-mix differences between 





Prevalence of Nonadherence 
Overall Nonadherence 
Our study data supported Hypothesis 1a that nonadherence to dietary restrictions 
is higher than nonadherence to medical aspects of treatment regimes, namely dialysis 
exchanges and medication. A total of 20%, 47% and 75% of the patients were classified 
as nonadherent to dialysis, medication and diet respectively based on self-report. These 
rates were higher than those reported in most other studies (e.g., DeOreo, 1997; Fine, 
1997; Holley & DeVore, 2006; Juergensen, Gorban-Brennan, & Finkelstein, 2004; Katzir 
et al., 2010; Lam et al., 2010; Russo et al., 2006), though part of the high prevalence of 
nonadherence can be attributable to the stringent criterion used for defining nonadherence 
in this study. For instance, some studies defined nonadherence as using less than 90% of 
the prescribed dialysate (e.g., Fine, 1997) or skipping two treatments per month or more 
(DeOreo, 1997), whereas our study defined nonadherence as ever deviating from 
treatment requirements. Notwithstanding, our reported nonadherence rates appeared quite 
high even when compared with a study using similar definition of nonadherence as us. 
Lam et al. (2010) investigated 173 CAPD patients in Hong Kong and reported the 
nonadherence rates to be 7% for dialysis, for 17% medication and 62% for diet. 
Biochemical data showed that 19% of patients had potassium < 3.5 mmol/l and 33% 
had phosphate > 1.78 mmol/l, comparable to previous findings (Hecking et al., 2004; 
Leggat et al., 1998; O'Connor, Jardine, & Millar, 2008). Both potassium and phosphate 
levels are traditional biochemical markers used to indicate nonadherence to medication 
and diet (Denhaerynck et al., 2007). Nonadherence rates estimated by biochemical values 
were lower than self-reports which were 47% for medication and 75% for diet. This was 
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in line with the notion by Kugler et al. (2011) that self-report, when used in an 
unthreatening way, was more capable of detecting minor nonadherence than biochemical 
markers. The rate of nonadherence to albumin was 88%, remarkably higher than previous 
studies (Russell et al., 2008; Sehgal, Leon, & Soinski, 1998). This is a cause for concern, 
given that serum albumin level is a robust associate of high mortality and morbidity in 
patients with and without renal diseases (Goldwasser & Feldman, 1997; Owen, Lew, Liu, 
Lowrie, & Lazarus, 1993). 
Nonadherence based on biochemical values were not associated with all self-
report nonadherence scores, consistent with previous studies (Chiu et al., 2009; Kaveh & 
Kimmel, 2001; Lee & Molassiotis, 2002). One reason for the lack of concordance 
between the two methods is likely to be due to differences in time measurement. It is also 
important to note that biochemical levels are likely to be influenced by a variety of 
factors such as comorbidity, dialysis adequacy, residual renal function, time at which the 
tests were performed and acid-based and hormonal status (Denhaerynck et al., 2007). In 
addition, biochemical values may be affected by “white coat adherence” noted in 
different populations which means patients tend to have good adherence several days 
preceding a clinic visit and much less satisfactory adherence in other days (Podsadecki, 
Vrijens, Tousset, Rode, & Hanna, 2008).  
Comparison of Nonadherence to Dialysis, Medication and Diet 
Nonadherence to dialysis exchanges was high. This is most probably supported by 
patients’ high awareness about the importance of dialysis, family enforcement, and the 
comfort of doing dialysis at home. PD patients do not need to be concerned about 
transportation, a common cause of nonadherence in HD patients (Latham, 1998). 
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Moreover, some patients are more motivated to adhere to dialysis because they hold the 
misconception that dialysis can compensate for their violations in other domains of the 
therapeutic regimen (Smith et al., 2010). 
Nonadherence to medication fell between nonadherence to dialysis and diet. As 
mentioned above, patients in our study had elevated level of concerns about the 
disruptive effects (e.g., side effects, drug dependence) of their prescribed medication 
when compared to other populations (Horne & Weinman, 1999; Rees et al., 2010).This 
might be an important contributor of medication nonadherence in this group. In addition, 
patients may be discouraged to take medication when they hold the belief that dialysis is 
enough to keep their health, as medicines produce no immediate symptomatic relief and 
they frequently receive information regarding the effects of medicines from alternative 
therapists (e.g., practitioner of Chinese medicine), other patients and friends that conflicts 
with physicians’ suggestions (Donovan & Blake, 1992; Karamanidou, Clatworthy, et al., 
2008).   
Dietary nonadherence was the greatest of the three, consistent with previous 
findings (Lam et al., 2010; Leggat et al., 1998). This supports the notion that 
nonadherence is very likely to occur when it requires major changes in lifestyle (Arenas 
et al., 2010). Following dietary guidelines is especially challenging for patients in 
countries where there is a huge discrepancy between traditional eating preferences and 
dietary needs for dialysis patients (Lam et al., 2010; Park, Choi-Kwon, Sim, & Kim, 
2008). Eating out is common in Singapore, as testified by the abundance of food courts 
and restaurants in the country. However, commercially prepared food usually contain 
high fat, cholesterol and salt (Ang & Foo, 2002) and is considered unhealthy for dialysis 
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patients. Thus, patients need to make food choices cautiously when they eat out because 
the alternative would be to eat unpalatable food at home. This restricted diet can be very 
distressing for patients. Nonadherence is especially likely to occur among patients with 
low frustration tolerance (De-Nour & Czaczkes, 1972). Even for patients who succeed in 
adjusting to renal dietary plans, dietary abuse can appear in social occasions because the 
collectivist culture in Singapore expects people to cater to the needs of others and 
suppress their own needs, such as in the case of “Guanxi” (McCarthy et al., 2009; 
Triandis, 2001). For patients with unsuccessful dietary adherence, guiding them to cope 
with frustration and to be more assertive may be helpful. 
Intentional and Unintentional Nonadherence 
 Intentional nonadherence to each domain of the treatment regimen was 
considerable, 28%, 58% and 81% for dialysis, medication and diet respectively. 
Unintentional nonadherence rates were also high, 19%, 71% and 73% for dialysis, 
medication and diet, respectively.  
Hypothesis 1b that unintentional nonadherence is more common than intentional 
nonadherence was not supported by our data based on mean scores, in contrast with 
findings in other chronic illness conditions (Rees et al., 2010; Sewitch et al., 2003; Unni 
& Farris, 2011). Part of the discrepancy may be related to mode of administration. The 
questionnaire developed by Morisky, Green and Levine (1986) was used to assess 
intentional and unintentional nonadherence in other studies. It asks patients about 
nonadherence directly (e.g., “Do you ever forget to take your medicines?”). Patients may 
feel more comfortable to cite forgetfulness to justify their nonadherence rather than 
admitting deliberate deviations since the former is less blamable (Unni & Farris, 2011). 
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We have opted for patient self-report administration to an independent researcher not 
involved with patients’ care in a confidential setting outside the clinic to minimize social 
desirability bias. All items were carefully phrased in a nonjudgmental manner to validate 
experience and facilitate disclosure (e.g., “Some people forget to take their medicines. 
Overall, how often does this happen to you?”). Such an approach has been recommended 
as effective in reducing response bias in self-report (Vlaminck et al., 2001). As there is no 
previous work on intention/unintentional nonadherence in ESRD patients, further work is 
needed to examine if the discrepancy may be somehow related to this population per se 
rather than the methodology. 
It is noteworthy that although intentional nonadherence seems puzzling to health 
providers, it may be more understandable when viewed from patients’ perspectives. 
Intentional nonadherence can be positively reinforced in daily life. For instance, Eliasson 
et al. (2011) interviewed a group of chronic myeloid leukemia patients and reported that 
patients’ intentional nonadherence to medication could be encouraged by the reduction of 
symptoms following altering drugs’ doses and by perceived doctors’ unintentional 
reassurance that occasional deviations would not lead to detrimental consequences. 
Moreover, nonadherence to HD regimen and remaining sick had been found helpful for 
patients to gain attention from others and to resolve family problems (De-Nour & 
Czaczkes, 1972). On the other hand, adherence can be negatively reinforced. Patients 
may experience no adverse effects when reducing or stopping therapy for some time, but 
may feel tiredness, itching and headaches caused by the treatment (Polaschek, 2007). 
Renal nurses commented in the study of McCarthy et al. (2009) that PD patients were at 
greater risk of being marginalized by their social network if they followed their treatment 
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guidelines as instructed. For instance, if patients kept their rooms very clean, it might 
discourage others from visiting due to concerns about causing infections to patients. In 
addition, PD patients have more chances to intentionally modify some aspects of their 
therapy such as starting time and the length of dialysis, since they are not dependent on 
the fixed schedule in dialysis centers (Polaschek, 2007).   
Patients’ attributes of foresight and foreplanning have been proven to be an 
important predictor of unintentional nonadherence (Daleboudt et al., 2010). However, 
this may not play a major role in this study, as even though cognitive decline is common 
among older dialysis patients (Tyrrell, Paturel, Cadec, Capezzali, & Poussin, 2005), they 
did not report more forgetfulness than younger patients. In addition, unintentional 
nonadherence could be caused by patients’ poor comprehension about their treatment and 
language barriers (Browne & Merighi, 2010). Education from pharmacists has been 
found to be effective in reducing patients’ difficulty about remembering medicines 
(Sathvika, Naraharib, Gurudevb, & Parthasarathia, 2009).      
Comparison of Nonadherence Between APD and CAPD Patients 
APD patients reported lower level of nonadherence than CAPD patients. More 
specifically, APD was associated with less intentional nonadherence to dialysis 
exchanges than CAPD in multivariate analysis and it was less common for APD patients 
to shorten their treatment in univariate analysis. Bernardini et al. (2000) also evaluated 
nonadherence to dialysis prescriptions in these two groups and noted elevated 
nonadherence in CAPD patients than APD patients. This result is not surprising, given 
the distinct CAPD and APD demands. CAPD involves performing several exchanges 
manually during the day time, whereas APD is performed at night by a mechanical 
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device when patients are sleeping. Thus CAPD patients may face more barriers in terms 
of time (e.g., going out for no more than 4 hours), space (e.g., employers searching for 
space to perform exchanges) and physiological status (e.g., continuous inter-abdominal 
pressure) than APD patients (Liakopoulos & Dombros, 2009).  
Determinants of Nonadherence 
Our results show that nonadherence is a multi-faceted phenomenon, concurrently 
determined by the interplay of five categories identified by WHO (Sabaté, 2003) as 
critical for nonadherence. They are: social-economic factors, health care system related 
factors, condition-related factors, therapy-related factors and patient-related factors. The 
relationship between these five categories and predictors spotted in our study is displayed 
in Table 20. 
Demographics and Nonadherence 
Our study identified a set of demographical variables (age, gender, ethnicity, 
education and housing condition) associated with nonadherence based on multivariate 
analyses. They generally made small contributions to the prediction of nonadherence 
outcomes, except when nonadherence was based on phosphate and albumin levels. 
Several systematic reviews report that demographic variables (excluding age and 
smoking) are inconsistent correlates of nonadherence (Karamanidou, Clatworthy, et al., 







Table 20:WHO Identified Categories Affecting Nonadherence and Significant Predictors in Our Study  
WHO Identified Categories Affecting Nonadherence and Significant Predictors of 
Nonadherence in Our Study  
Five categories affecting nonadherence 
Significant predictors of nonadherence  
in our study 
Social-economic factors  Demographics (age, gender, 
ethnicity, education level and 
housing condition)  
 WHOQOL-BREF environment 
Health care system-related factors    KDQOL-SF patient satisfaction  
Condition-related factors  Comorbidity  
 Primary cause of ESRD 
Therapy-related factors  PD modality 
 Time on dialysis 
Patient-related factors  BMQ concerns  
 Self-efficacy  
 HADS depression 
 HADS anxiety  
 
Age. Patients who were older had less unintentional nonadherence to medication, 
less intentional nonadherence to dietary demands and less likelihood of phosphate > 1.78 
mmol/l than younger patients in the current sample. Older age is a consistent predictor of 
less nonadherence to all aspects of the medical regimen in other studies (Ismail, Hakim, 
Oreopoulos, & Patrikarea, 1993; Kugler et al., 2005; Lam et al., 2010). The association 
between younger age and nonadherence may reflect the practical and logistic challenges 
in sustaining care and following treatment as the younger patients are more likely to be 
occupationally and socially active (van der Mei et al., 2007). Younger patients also find it 
difficult coming into terms with their sickness and tend to have poor tolerance about 
104 
 
limitations associated with treatment (Dimkovic & Oreopoulos, 2000; Gonsalves-
Ebrahim, Sterin, Gulledge, Gipson, & Rodgers, 1987; Herlin & Wann-Hansson, 2010). 
Nonadherence can help younger patients to deny their dependence on dialysis and the 
severity of their condition (De-Nour & Czaczkes, 1972). This can be further exacerbated 
by younger patients’ perception of a lack of support from family members, doctors, 
nurses, and technicians (Oka & Chaboyer, 1999).  
Older age was also found to be associated with reduced albumin level in our study, 
although due in part to albumin level tending to decrease steadily with age (Greenblatt, 
1979; Salive et al., 1992). It is also plausible that older patients do not take in adequate 
amount of protein due to reduced appetite (Park et al., 2008). 
Gender. Females were 1.5 times more likely to have phosphate > 1.78 mmol/l 
than males, indicating possible dietary or medication violations. Another study also 
reported a higher level of fluid nonadherence among females than males (Chilcot, 
Wellsted, & Farrington, 2010). In contrast, other studies suggested that males are more 
nonadherent to all aspects of renal regimen than females (Bame, Petersen, & Wray, 1993; 
Lam et al., 2010; O'Connor et al., 2008; Setoguchi, Choudhry, Levin, Shrank, & 
Winkelmayer, 2010). Asefzadeh, Asefzadeh and Javadi (2005) revealed that female 
patients were less likely to be adherent than male patients because of forgetfulness, 
doubts about the importance and necessity of medicines and religious considerations. In 
the current study, females did not report more nonadherence in survey but showed 
elevated phosphate levels. Chen et al. (2006) suggested that some patients adhere to their 
medical regimen wrongly, such as when patients think that they are duly following 
doctors’ instruction but in fact their methods are not correct. This is probably the case 
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with some female patients in our study. Interestingly, females are also more responsive to 
educational interventions about nonadherence (Barnett, Li Yoong, Pinikahana, & Si-Yen, 
2008). Another reason to explain the gender difference on self-report and phosphate level 
might be that females feel more reluctant about reporting nonadherence than males, since 
females tend to have more concerns about others’ evaluation of them than males 
(Hoffman, 1977).      
Ethnicity. The Chinese were less likely to forget taking their prescribed 
medication in our study than non-Chinese. The cohesion of Chinese families might play 
an important role in this. Closer ties amongst family members can facilitate patients’ 
medication adherence through providing financial resources, increasing motivation, 
educating patients about the dosing and effects of medicines, setting reminders or directly 
administrating medications (Fredriksen-Goldsen et al., 2011).  
Education level. Patients with high education (post-secondary school) reported 
more intentional deviation from dialysis guidelines than patients with low educational 
level (no or primary school) in our study, whereas the difference between patients with 
intermediate education (secondary school) and patients with low education was not 
significant. Our finding is in contrast with other studies such as Lam et al. (2010) which 
reported a negative association between education level and nonadherence to dialysis, 
fluid and dietary restrictions. Comparing patients on different educational levels revealed 
that 39% patients with high education were still working while only 15% patients with 
low education were still working. Patients with high educational level were also younger 
than patients with low education level (data not shown). Thus patients with high 
education level might be occupationally and socially more active and their daily activities 
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might have more conflicts with the rigorous demands of their medical regimen. Patients 
with busy or unpredictable schedules are found to be less likely to be adherent in other 
studies (Browne & Merighi, 2010).   
Housing condition. Patients living in more expensive property (5-rooms 
flats/condominiums or above) had a lower risk of malnutrition (indicated by albumin 
level) than patients living in less expensive property (1-4 rooms flats). Housing condition 
was used as a rough indicator of patients’ financial status in our study, since there were 
many missing values for monthly family income. Poor financial status is a barrier to 
adequate protein nutrition amongst dialysis patients, since renal diet can be expensive to 
maintain (Sehgal et al., 1998; Soinski, Kelly, & Komaransky, 1993). 
Clinical Variables and Nonadherence 
The association between PD modality and nonadherence has been discussed 
above. Other factors affecting nonadherence involved time on dialysis, comorbidity and 
primary cause of ESRD. Clinical factors were also found to be poor predictors of 
nonadherence in literature (Karamanidou, Clatworthy, et al., 2008).  
Time on dialysis. Patients on PD for more than two years were more likely to 
intentionally deviate from their dialysis guidelines than patients treated with PD for less 
than one year. Difficulty in sustained motivation in long-term dialysis patients is 
commonly documented (Lam et al., 2010). It has also been suggested that patients follow 
doctors’ advice initially when they are unfamiliar with their disease and treatment. As 
they become more knowledgeable about their treatment gradually through their 
observations and body reactions, they intentionally adjust certain aspects of their 
treatment to feel better or to regress back to their previous lifestyle (Polaschek, 2007).  
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Comorbidity. Comorbidity was the only factor associated with potassium level 
below clinical target. A positive relationship between comorbidity and nonadherence has 
also been observed in other studies (Pang, Ip, & Chang, 2001; Setoguchi et al., 2010). 
Patients with higher number of comorbid diseases may have more physical or emotional 
difficulties about being adherent to potassium. Dependence on carers for shopping and 
cooking also predispose patients to nonadherence in literature (Lee & Molassiotis, 2002; 
Sehgal et al., 1998), but our study could not confirm these results. 
Primary cause of ESRD. Patients with diabetes and hypertension as primary cause 
of ESRD showed less intentional nonadherence to medication than patients with other 
causes of ESRD (e.g, systemic lupus erythematous). Diabetic status was also found 
associated with less nonadherence in another study (Christensen, Benotsch, Wiebe, & 
Lawton, 1995). It has been observed in different populations that patients stop taking 
medicines as soon as there is a reduction of symptoms (Addington, 1979; Britten, 1994). 
Given that both diabetes and hypertension are asymptomatic, it is very likely that patients 
with these conditions are more aware about the importance of being adherent to 
medication regimen regardless of symptoms due to previous experience with diabetic and 
hypertension regimen.   
It is noteworthy that PD patients in our study had a very high pill burden, taking a 
median of 10 types of medication per day. Contrary to two previous studies (Chiu et al., 
2009; Neri et al., 2011), our study detected no association between pill burden and 
medication nonadherence. This discrepancy may be due to the fact that the other two 
studies used the exact number of tablets (dosages per day), whereas we only evaluated 
the number of prescribed medicines and this parameter might be less sensitive.  
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Psychosocial Variables and Nonadherence 
 Health beliefs. Hypothesis 2a that positive health beliefs (i.e., high necessity 
beliefs, low concern beliefs and high self-efficacy) are associated with less nonadherence 
was partially confirmed. Self-efficacy and concern beliefs had a major impact on 
nonadherence to diet and medication, but not on nonadherence to dialysis exchanges. The 
lack of association between dialysis nonadherence and health beliefs may be due to the 
fact that dialysis presents a more immediate gratification of their illness, thus involving 
less rational decision making. 
 In our study higher level of concern beliefs were associated with more intentional 
nonadherence to medication. This is in line with studies in other patient populations 
(Daleboudt et al., 2010; Lowry, Dudley, Oddone, & Bosworth, 2005). It is 
understandable that patients’ intentional nonadherence to medication was affected by 
concern beliefs in our sample. Dialysis patients may become more sensitive to the costs 
associated with taking medication (e.g., side effects, drug dependence) after they have 
already experienced multiple losses such as functional decline, unemployment and 
reduced social life (Chan, Brooks, Erlich, Chow, & Suranyi, 2009). Thus the need to 
prevent further losses takes over and leads to intentional deviations from medication 
guidelines. The observed inverse association between concern beliefs and unintentional 
nonadherence to diet is noteworthy as unintentional nonadherence is not typically thought 
of as an active process (Clifford et al., 2008). Other studies (Daleboudt et al., 2010; Unni 
& Farris, 2011) also reported that concern beliefs played an important role in 
unintentional nonadherence to medication. It seems that concerns may somehow lead to 
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patients attaching low priority to treatment which may lead to more forgetfulness. More 
work using qualitative method is needed to explore these relationships. 
Some concerns may be fueled by a lack of understanding of how the drugs work, 
it is also important to remember that these concerns may be well validated by patients’ 
subjective experience and not solely founded by a lack of understanding or poor 
knowledge (Schuz et al., 2011). The finding of the role on concerns beliefs driving 
nonadherence highlights the need to correct patients’ misperceptions and worries about 
side effects. Corrective actions need to be taken either in the form of educating patients 
about drug effects or when the situation calls, changing prescribed drug (there may for 
instance be another hypertensive agent that the health care professions could prescribe if 
one is not that well tolerated) so as to reduce risk of intentional deviation from prescribed 
medication regimen.  
Self-efficacy influenced most nonadherence measures (intentional/unintentional 
nonadherence to medication/diet) in our study. This is in line with the finding of Smith et 
al. (2010) that sense of self-responsibility and perceived capability of self-restriction are 
critical facilitators of adherence. There is overwhelming theoretical and empirical 
evidence on the role of self-efficacy in guiding adherence and self-care management in 
populations with different chronic illnesses (Lindberg & Fernandes, 2010; Mo & Mak, 
2009; Taal, Rasker, Seydel, & Wiegman, 1993; Zrinyi et al., 2003). Self-efficacy training 
in HD patients has been found to be effective in reducing weight gains (Tsay, 2003). 
Incorporating self-efficacy into a self-management programme for PD patient achieved 
successful effects in terms of enhancing volume status, quality of life, rehabilitation 
status, and reducing nonadherence to dialysis and dietary guidelines (Su et al., 2009).  
110 
 
Dialysis patients face a range of adherence barriers such as debilitating symptoms, 
a lack of motivation and conflicts between therapy and other life activities (Polaschek, 
2007). The importance of self-efficacy is that it “determines whether coping behavior 
will be initiated, how much effort will be expended, and how long it will be sustained in 
the face of obstacles and aversive experiences” (Bandura, 1977, p. 191). Thus patients 
with stronger self-efficacy are very likely to view their treatment demands as challenging 
tasks to be mastered, actively participate in solving their problems and remain resilient 
when their efforts do not achieve desirable effects immediately. On the other hand, 
patients with low self-efficacy are very likely to judge treatment tasks as too difficult for 
them and thus give up quickly when they encounter barriers in managing their treatment 
or when they do not see effects of adherence in short term (Bandura, 1989). 
Bandura (1977) proposed four sources of self-efficacy: mastery experience, 
vicarious experience, verbal persuasion and physiological states. Strategies corresponding 
to these postulates can be effective in enhancing self-efficacy in PD patients, such as: (a) 
providing adequate training to ensure that patients master necessary knowledge and skills 
and helping patients achieve successes at the initiation of dialysis; (b) using social model 
and asking successful patients to share their adherence experiences and tips so other 
patients can learn from them; (c) reassuring patients that they are capable of 
accomplishing the tasks; (d) helping patients to reduce stress and view emotional and 
physiological arousals as facilitators instead of barriers to adherence (Bandura, 2006; 
Locke & Latham, 2002). 
Given the importance of cognitive factors (i.e., beliefs about medicines and self-
efficacy), it is imperative to take them into account in interventions aimed at reducing 
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nonadherence. Little success is found in previous educational programmes which 
increased patients’ understanding about treatment but failed to change patients’ health 
beliefs and self-efficacy (Cummings, Becker, Kirscht, & Levin, 1981; Karamanidou, 
Weinman, & Horne, 2008; Tanner et al., 1998).   
Emotional distress and nonadherence. Hypothesis 2b that more emotional distress 
is associated with more nonadherence was confirmed in univariate analyses, but negated 
in multivariate analyses after controlling for covariates. The relationship between 
depression and nonadherence is well supported in different studies (Brownbridge & 
Fielding, 1994; Cukor et al., 2009; De-Nour & Czaczkes, 1976). A rigorous review 
reported a considerable relationship between depression and nonadherence across 
different chronic illnesses, with depressed patients three times as likely as non-depressed 
patients to be nonadherent (OR = 3.03, 95% CI = [1.96, 4.89]) (DiMatteo et al., 2000). 
However, the association between anxiety and nonadherence is ambiguous in current 
literature (DiMatteo et al., 2000). The association between anxiety and nonadherence in 
dialysis patients was confirmed in one study (Brownbridge & Fielding, 1994) but negated 
in three other studies (Christensen, Moran, Lawton, Stallman, & Voigts, 1997; Katz et al., 
1998; Schneider et al., 1991).  
A significant finding of our study is that emotional distress only affects 
nonadherence indirectly through cognitions. More specifically, depression and anxiety 
affect nonadherence through increasing patients’ concerns about the adverse effects of 
medicines and lowering patients’ self-efficacy about achieving treatment goals. This 
result has important clinical implications, since it suggests that modifying beliefs may be 
a feasible way to reduce nonadherence in depressed patients.  
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 Quality of life and nonadherence. Two quality of life parameters turned out to be 
important in predicting nonadherence outcomes: KDQOL-SF patient satisfaction and 
WHOQOL-BREF environment.  
Patient satisfaction was the most important predictor of intentional nonadherence 
to dialysis in our study. Patients’ satisfaction with their nephrologists has also been found 
associated with better attendance at HD sessions (Kovac, Patel, Peterson, & Kimmel, 
2002). Low satisfaction with care can fuel patients’ nonadherence. A tense doctor-patient 
relationship lowers the perceived authority of health providers. Patients view those by-
the-book treatments given by the doctors as not to their best interest and have a tendency 
to use their subjective experience to modify their treatments (Allen, Wainwright, & 
Hutchinson, 2011). For instance, patients experiment with their medication to find out 
minimum dosage workable for them and to control side effects instead of following 
doctor’s advice blindly (Donovan, Blake, & Fleming, 1989; Vermeire et al., 2001). In 
addition, nonadherence could be a way of “acting out”, used by passive-aggressive 
patients to express their underlying hostility towards the medical team who did not treat 
them well (De-Nour & Czaczkes, 1972). Furthermore, patients are apt to conceal their 
nonadherence behaviors from health providers, and when they do so, it blocks out 
necessary discussion regarding the appropriateness of such behaviors (Allen et al., 2011; 
Donovan & Blake, 1992). The importance of patients’ faith in their doctors is testified by 
reports of healthy physician-patient relationship related to adhering to treatment plans 
even when facing severe physical and social stressors (Eliasson et al., 2011).    
Good environment quality of life decreased nonadherence to dialysis guidelines. 
Patients with better environmental quality of life are more likely to have adequate 
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resources (e.g., financial, informational) to secure their needs, gain easy accessibility to 
health care when problems arise, have better chances to participate in recreational 
activities to alleviate stress and a more favorable home environment (e.g., safety, ease of 
transportation, low noise). All these factors can help patients establish a positive attitude 
towards dialysis which has been found to be important in motivating patients to perform 
exchanges. This is well illustrated by the comment of a patient in the study of Polascheck 
(2007): “If life is going well, then dialysis is not a problem.” 
Comparison of Determinants of Intentional and Unintentional Nonadherence 
There is theoretical and empirical evidence to show that intentional nonadherence 
to medication is largely driven by patients’ motivation and beliefs (Branin, 2001; George, 
Kong, & Stewart, 2007). These are factors largely amenable to change. In contrast, 
unintentional nonadherence to medication is thought to be the result of a passive process 
that is less strongly associated with individuals' beliefs and more closely related to 
patients’ skills or their abilities to follow their medication regimen (e.g. age, manual 
dexterity, cognitive impairment, health literacy) or treatment factors (e.g. dose, 
complexity) (Clifford et al., 2008).  
However, predictors of intentional and unintentional nonadherence were not 
clearly separated in our study. Intentional nonadherence was determined by the interplay 
of age, education, PD modality, primary cause of ESRD, patient satisfaction, 
environment quality of life, concern beliefs and self-efficacy, whereas unintentional 
nonadherence was affected by age, ethnicity, time on dialysis, environment quality of life, 
concern beliefs and self-efficacy. Thus, age, environment quality of life, concern beliefs 
and self-efficacy were all predictors of both intentional and unintentional nonadherence. 
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One possible reason could be that there was moderate to high overlap between patients 
reporting intentional nonadherence and unintentional nonadherence (Spearman 
correlation, rs = .35 for dialysis, rs = .56 for medication, rs = .67 for diet, all ps < .001). 
This is not unexpected since factors such as a busy life schedule can simultaneously 
contribute to intentional and unintentional nonadherence. Nonadherence is not a 
dichotomy of intentionality. For instance, patients forgetting to take medication at lunch 
may intentionally increase dosage at dinner (Eliasson et al., 2011). 
Clinical Recommendations 
It has been advocated that views concerning nonadherence should be expanded 
from merely focusing on patients as cause of nonadherence to considering the 
interactions between patient, health provider and the wider health care system (Kammerer, 
Garry, Hartigan, Carter, & Erlich, 2007). We agree that health providers are essential in 
preventing patients’ nonadherence. In order to do this, there are several suggestions. 
Firstly, the extensiveness of nonadherence should be noted, especially regarding dietary 
restrictions. Few patients discuss their nonadherence behaviors with physicians without 
prompting (Allen et al., 2011; Donovan & Blake, 1992). This may give physicians the 
wrong impression that few patients are nonadherent (McHorney, 2009). Patients also feel 
frustrated if doctors do not check upon them regarding their therapy (Polaschek, 2007). 
Thus it is crucial for physicians to become aware of this issue and provide consultations 
for patients claiming difficulties about following doctors’ instructions. As shown in our 
results, patients are willing to acknowledge nonadherence when asked in a non-
threatening, non-authoritative way. Secondly, intentional and unintentional nonadherence 
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are different phenomena. The intentionality of nonadherence should be considered in 
designing interventional programmes to reduce nonadherence. It should be pointed out 
that it is common to suggest behavioral strategies such as timer-alarms and medication 
boxes to patients reporting forgetfulness about therapy (Unni & Farris, 2011). Our results 
showed that these strategies alone are not likely to be effective without considering 
patients’ beliefs (self-efficacy and beliefs about medicines). Thirdly, it is notable that 
nonadherence is determined by a complex interplay of social-economic factors (age, 
gender, ethnicity, education level, housing condition and environment quality of life), 
health care team related factors (patient satisfaction), condition-related factors 
(comorbidity and primary cause of ESRD), therapy-related factors (PD modality and time 
on dialysis) and patient-related factors (medicine beliefs, self-efficacy, depression and 
anxiety). Social-economic, condition and therapy related factors are less modifiable than 
other factors. Patients with younger age, female gender, non-Chinese ethnicity, high 
education, poor housing condition, poor environment quality, high comorbidity, primary 
cause of ESRD not being diabetes or hypertension, and longer time on dialysis should be 
monitored for risk of nonadherence. For patients consistently showing nonadherent 
behaviors while on CAPD, switching to APD may be a solution (Raj, 2002). Patients’ 
cognitions, emotions and satisfaction with care are also critical determinants of 
nonadherence and they are more modifiable in interventions. Health providers can play 
an important role in reducing nonadherence through ways such as opening up 
communication regarding nonadherence, addressing patients’ concerns about medication 
and providing assurance that patients have adequate self-care abilities. A specific strategy 
suggested in literature that can be quite useful in this population is regular phone calls 
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from health providers (physicians, nurses or pharmacist) (Eliasson et al., 2011). Phone 
calls serve as reminders for patients to follow treatment guidelines and at the same time 
enhance patients’ relationship with medical staff and reduce patients’ uncertainty 
regarding their disease and treatment. Implementing this strategy has been proven to be 
effective in improving quality of life, resolving patients’ concerns and reducing 
nonadherence among PD patients and patients with other chronic conditions (Chow & 
Wong, 2010; Clifford, Barber, Elliott, Hartley, & Horne, 2006; Eliasson et al., 2011). 
Another more time-consuming strategy is negotiated care in which patients take an active 
role making decisions regarding their prescriptions. This strategy produced marked 
outcomes in a group of diabetic PD patients, reducing patient nonadherence to dietary salt 
and fluid restriction from 80.5% to 23.8% (Quan et al., 2006).  
Study Strengths and Limitations 
This study has several important strengths. Firstly, our study sample was highly 
representative of Singapore PD patients. It comprised almost one quarter of all local PD 
patients and had similar age, gender, ethnicity and primary cause of ESRD as the overall 
PD population in Singapore. Selection bias was minimized in our study. Participants were 
not limited to those who could read and completed the questionnaires by themselves. 
Patients could participate in our study through different ways based on their preferences 
for time, location and language. This prevented loss of patients due to poor health 
condition, illiteracy, visual problems and language barriers. Secondly, this is the first 
systematic study to investigate prevalence and predictors of intentional and unintentional 
nonadherence in PD patients. A series of determinants of intentional and unintentional 
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nonadherence were identified, thus offering multiple choices for targeting nonadherence. 
In addition, our study provided critical information regarding health beliefs, emotional 
distress, quality of life and nonadherence for patients on APD and CAPD. This can 
facilitate better management of PD programme and help patients’ selection of PD 
modality. 
Limitations of our study should be noted. Regression models in our study only 
explained low to moderate variance in nonadherence outcomes. More than half of the 
variance was not tapped in our study. Our study failed to assess some important 
associates of nonadherence such as cognitive decline (Daleboudt et al., 2010) and 
smoking status (Kugler et al., 2011; Russell et al., 2007) as well as factors beyond 
patients’ control such as cost of medicines (Hirth, Greer, Albert, Young, & Piette, 2008). 
In addition, we did not assess patients who did not show up for their regular clinics. Since 
patients who miss their clinic appointments are also more likely to be nonadherent with 
other aspects of the therapeutic regimen (Daleboudt et al., 2010), nonadherence rates in 
our study might be underestimated. Moreover, we used adapted questionnaires in 
assessing dialysis, medication and dietary self-efficacy and nonadherence. Since the 
psychometric properties of these two questionnaires have not been tested in other studies, 
findings regarding nonadherence and self-efficacy should be interpreted with caution.  
It should also be noted that about half of the participants were interviewed by 
research assistants. Interviewed patients may tend to give favorable responses due to 
social desirability issue. However, all analyses did not control for patients’ participation 
method because there were 12 missing items for this variable. These missing items would 
lead to loss of power and increase type II error in data analyses. Our current sample size 
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(n = 144) is powerful enough to detect medium effect sizes but underpowered to detect 
small effect sizes based on G*power 3.1 (Faul et al., 2009) calculations. Post-hoc power 
(1) = .83, .81, .79 for independent t, Mann-Whitney tests and regression analyses 
respectively when fixing  = .05 and effect sizes to be medium. A sample size of 394 for 
each group is required to detect a small effect size of d = .2,  = .05, power (1) = .8 for 
two-tailed independent t test. A sample size of 412 for each group is required to detect a 
small effect size of d = .2,  = .05, power (1) = .8 for two-tailed Mann-Whitney test. 
For linear regression with 17 predictors, a sample size of 1000 is required to detect a 
small effect size of 2 = .02,  = .05, power (1) = .8. Thus, it is necessary to continue 
the research with more participants in order to detect small effect sizes.  
Future Studies 
Our study makes the first attempt to distinguish intentional and unintentional 
nonadherence in ESRD patients and to identify associated factors. More studies are 
required to test whether findings in our study can be repeated in PD patients from other 
regions or be generalized to other ESRD populations (e.g., HD, transplant patients). 
Moreover, since this is an observational study, we can only evaluate factors affecting 
absolute nonadherence. It has been recognized that factors maintaining nonadherence are 
different from factors changing nonadherence (Friend, Hatchett, Schneider, & Wadhwa, 
1997). Longitudinal studies are needed to describe the dynamics of nonadherence as the 
renal disease progresses and identify relevant predictors.  
Our study reported high prevalence of intentional nonadherence. However, 
intentional nonadherence does not always appear to be related with detrimental clinical 
119 
 
consequences. Some studies paradoxically identified a positive relationship between 
mortality and adherence (Park et al., 2008). This was interpreted using “reasoned 
adherence”, that is, patients decide to follow treatment guidelines only to a certain point 
to balance their treatment needs and their daily life needs (Nevins, 2002). This kind of 
behavior may reduce prescriptions errors by physicians, free patients from the helpless 
role and hence provide survival advantages (Leggat, 2005; O'Brien, 1990). More studies 
are required to ascertain the relationship between intentional nonadherence and clinical 
outcomes. 
Another direction worth mentioning is regarding the influence of carers on 
patients’ outcomes. Since PD is a home based therapy, carers are closely involved in 
patients’ treatment such as moving dialysis fluids, performing exchanges, and making 
critical medical decisions (Fan, Sathick, McKitty, & Punzalan, 2008). Carers of PD 
patients are vulnerable to poor mental health and have more diminished quality of life 
than those of HD patients (Belasco, Barbosa, Bettencourt, Diccini, & Sesso, 2006; Fan et 
al., 2008; Shimoyama et al., 2003). The implication of this on patients’ outcomes has 
been completely overlooked. It is possible that caring for PD patients may give rise to 









This study assessed health beliefs, emotional distress, quality of life and 
nonadherence in a representative cohort of APD and CAPD patients. High rates of 
nonadherence were observed for all three aspects of the medical regimen, i.e., dialysis, 
medication and diet, with dietary nonadherence being the most remarkable. Intentional 
nonadherence occurred more commonly than unintentional nonadherence, In addition to 
nonadherence, PD patients also exhibited unfavorable attitudes toward treatment regimen, 
poor emotional outcomes, and compromised quality of life. APD patients were more 
adherent than CAPD patients and CAPD patients reported higher self-efficacy about 
managing their medicines. No other differences between APD and CAPD patients could 
be demonstrated. More importantly, this study identified important determinants of 
nonadherence. The strongest predictors of self-reported nonadherence tend to be 
psychosocial factors instead of demographical and clinical factors. Health belief factors 
were found to be mediators in the relationship between emotional distress and 
nonadherence. These significant findings have important implications for the successful 
management of PD programme. Efforts aimed at improving patients’ communication 
with medical providers and addressing patients’ concerns about therapy or doubts about 
their own self-management capability are very likely to be effective in terms of reducing 
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Participation Information Sheet 
Appendix B:Participation Information Sheet 
1. Study Information 
Protocol Title: 
An evaluation of psychosocial and behavioural outcomes in patients on peritoneal 
dialysis regimes and their carers 
Principal Investigator & Contact Details: 
Dr. Marjorie Foo Wai Yin,  
Department of Renal Medicine,  
Singapore General Hospital, 
Tel: (65) 63214436 
Email: marjorie.foo.w.y@sgh.com.sg 
2. Purpose of the Research Study 
You are invited to participate in a research study.  It is important to us that you first 
take time to read through and understand the information provided in this sheet.  
Nevertheless, before you take part in this research study, the study will be 
explained to you and you will be given the chance to ask questions. After you are 
properly satisfied that you understand this study, and that you wish to take part in 
the study, you must sign this informed consent form.  You will be given a copy of 
this consent form to take home with you. 
You are invited because we are approaching patients with kidney disease who are 
receiving peritoneal dialysis (PD) under the care of the Renal Clinicians at 
Singapore General Hospital. Individuals who are over the age of 21 years, have 
been on PD for at least 90 days and are willing to participate are welcome. Patients 
judged by the senior staff members as too ill or likely to be distressed by taking 
part in the present study will be excluded from participating.  
This study is carried out to explore patients’ experience with their dialysis regime, 
diet and medication and to explore any difficulties they may be facing in their life 
and overall adjustment due to their condition and/or treatment.  This study hopes to 
recruit 200 participants from Singapore General Hospital over a period of 24 
months. 
3. What procedures will be followed in this study  
The study will be conducted over a period of 24 months. You only need to 
participate once. If you decide to participate, you will need to sign a consent form 
and complete 8 questionnaires which assess treatment nonadherence, beliefs about 
medication, mood, quality of life, social isolation and sociodemographic domains. 
The questionnaires will either be completed independently by you (i.e. self-
administered) or administered by the research assistant in the form of a structured 
interview, according to your preference. This segment will span approximately 55 
to 70 minutes, depending on your reading and response speed. In addition, your 
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medical records will be reviewed based on your consent.  
Medical data will also be retrieved from your medical records. These will include: 
Blood pressure ratings, dialysis adequacy delivery indices (Kt/V); albumin, 
hemoglobin, potassium, phosphate, and peritoneal dialysis regime/dose. 
Information regarding, primary cause of kidney failure and date that you started on 
peritoneal dialysis will also be recorded.   
4. Your Responsibilities in This Study 
You will be required to complete 8 questionnaires asking questions about your 
treatment, mood and overall well-being. If you encounter difficulties in 
understanding the questions, you may seek assistance.  Should you feel 
uncomfortable or unwell during the assessment process, kindly inform the 
investigator and the assessment will be terminated without delay. 
5. Possible Risks and Side Effects 
We do not anticipate that answering the questionnaires entails any risk or are likely 
to cause any discomfort or distress to the participants. The questionnaires are 
selected on the basis of good psychological principles and are non-invasive. It is 
therefore not expected that the questionnaires would cause any harm, risk or 
discomfort to the respondent.  
6. Possible Benefits from Participating in the Study 
Most participants enjoy the opportunity to express their opinions about their 
experience and reflect on their behaviors and/or difficulties in managing the 
demands of illness and treatment. 
We hope and anticipate that patients will find sharing their experience useful. We 
also hope that this will also benefit future patients and carers. Your feedback and 
the knowledge gained from this study will help us evaluate the care delivered and 
if needed design a support intervention program for PD patients and carers to assist 
them in better manage their condition and improve their well-being. By gaining a 
better insight and understanding in patients and carers’ experiences, we will be 
able to develop a program specific to patients and carers’ needs in the local 
context.  
7. Costs & Payments if Participating in the Study 
Participation by both you and your carer will be collectively rewarded by a token 
fee of SGD 20. This will be covered by MOE ACRF start up research grant to Dr 
Konstadina Griva (Co- Investigator) and will be administered by the research 
assistants upon completion of questionnaires. 
8. Voluntary Participation 
Your participation in this study is voluntary. You may stop participating in this 
study at any time. Your decision not to take part in this study or to stop your 
participation will not affect your medical care or any benefits to which you are 




Your doctor, the Investigator and/or the Sponsor of this study may stop your 
participation in the study at any time if they decide that it is in your best interests. 
They may also do this if you do not follow instructions required to complete the 
study adequately. If you have other medical problems or side effects, the doctor 
and/or nurse will decide if you may continue in the research study.  
In the event of any new information becoming available that may be relevant to 
your willingness to continue in this study, you (or your legally acceptable 
representative, if relevant) will be informed in a timely manner by the Principal 
Investigator or his/her representative. 
9. Compensation for Injury 
The questionnaires have been carefully chosen to be completely non-invasive – 
none of the questionnaires is likely to pose any risk of harm or injury to you. As 
such there are no compensation arrangements in place. 
10. Confidentiality of Study and Medical Records 
Information collected for this study will be kept confidential. Your records, to the 
extent of the applicable laws and regulations, will not be made publicly available.  
However, Singapore Health Services (SHS) Centralised Institutional Review 
Board (CIRB) and Ministry of Health will be granted direct access to your original 
medical records to check study procedures and data, without making any of your 
information public. By signing the Informed Consent Form, you (or your legally 
acceptable representative, if relevant) are authorizing such access to your study 
and medical records. 
Data collected and entered into the Case Report Forms are the property of 
Singapore General Hospital and National University of Singapore. In the event of 
any publication regarding this study, your identity will remain confidential. 
11. Who To Contact if You Have Questions 
If you have questions about this research study or there are any injuries sustained 
during the course of this study, you may contact, 
 
Dr. Marjorie Foo Wai Yin, Principal Investigator  
Department of Renal Medicine,  
Singapore General Hospital, 
Tel: (65) 63214436 
Email: marjorie.foo.w.y@sgh.com.sg 
 
Dr Griva Konstadina, Co-Investigator  
Department of Psychology,  
National University of Singapore 
Tel: (65) 65163561  
Email: psygk@nus.edu.sg 




If you want an independent opinion of your rights as a research subject you may 
contact the SingHealth CIRB Secretariat at 6323-7515. 
If you have any complaints about this research study, you may contact the 









Appendix C: Consent Form 
Protocol Title: 
An evaluation of psychosocial and behavioural outcomes in patients on peritoneal  
dialysis regimes and their carers  
Principal Investigator & Contact Details: 
Dr. Marjorie Foo Wai Yin, Principal Investigator  
Department of Renal Medicine,  
Singapore General Hospital, 
Tel: (65) 63214436 
Email: marjorie.foo.w.y@sgh.com.sg 
I voluntarily consent to take part in this research study.  I have fully discussed and 
understood the purpose and procedures of this study.  This study has been explained to 
me in a language that I understand. I have been given enough time to ask any questions 
that I have about the study, and all my questions have been answered to my satisfaction.  
_______________________      ____________________ 
Name of Participant Signature Date                                       
 
Witness Statement 
I, the undersigned, certify to the best of my knowledge that the participant signing this 
informed consent form had the study fully explained in a language understood by him / 
her and clearly understands the nature, risks and benefits of his / her participation in the 
study. 
_______________________      ____________________ 
Name of Witness                   Signature Date          
 
Investigator Statement 
I, the undersigned, certify that I explained the study to the participant and to the best of 
my knowledge the participant signing this informed consent form clearly understands the 
nature, risks and benefits of her participation in the study. 
 
 _______________________  _______________________      _ ____________________ 
Name of Investigator /  Signature                                      Date 










Appendix D: Patient Demographic Information 
[1] What is your date of birth? (please write in MM/YYYY)  __________________ 
 
[2] What is your first language? (please write in) _______              ____________ 
 
[3] How would you describe your ethnic background?  
 
  1  Chinese  2  Malay 
  3 Indian   4 Asian Other 
  5 White   6 Other 
  7 Do not wish to answer  
 





5 Living with partner 
6 Other 
 




[6] Which of the following responses best characterises your current work activity or 
 employment status?  
 
  1   employed full-time  5   retired 
  2   employed part-time  6   looking after home and family 
  3   self-employed   7   student 
  4   unemployed, laid off involuntarily 8   other/none of the above 
 
[7] What approximately is the current estimated monthly income of your overall 
family? (Please remember your answers are confidential) 
 
   1     $ 0 -$ 2,000 
   2    $ 2,001 - $ 4,000 
3 $ 4,001 - $ 6,000 
4.  $ 6,001 – above 
5. don’t know 





[8] Which of the following best describes your housing:  
 
  1    1-2 HDB flat 
  2    3-4 HDB flat 
  3    HDB 5 room/executive/maisonette 
        4          Condominium, including executive condominium and private    
                    apartment 
  5    Terrace/ Semi – Detached / Bungalow 
  6    other (please specify__________________________________) 
 
[9]  How long have you been on peritoneal dialysis? _______________________ 
 
  1 Less than 1 month  
  2 6 to 12 months 
  3 13 to 24 months 




Appendix E  
Medical Form 
Appendix E: Patient Medical Information 
I. Comorbidities (please tick any that apply and list any additional) 
 
 Yes No 
Bone Disease   
Hypertension   
Diabetes (without end of organ damage)   
Diabetes (with end of organ damage)   
Myocardial infarction   
Congestive Heart Failure   
Peripheral Vascular disease   
Cerebrovascular disease   
Connective tissue disease   
Dementia   
Hemiplegia   
Leukemia   
Malignant lymphoma   
Malignant solid tumor in the last 5 years 
(metastatic) 
  
AIDS   
Peptic Ulcer Disease   
Liver disease (mild)   
Liver disease (moderate)   
Liver disease (severe)   
Renal disease (mild)   
Renal disease (moderate)   
Renal disease (severe)   
    
Please list any additional comorbid conditions_____________________________ 












II. Treatment Details 
 
Primary kidney disease diagnosis  
Type of current dialysis modality 





III. Biochemical data (most recent 2 values recorded) 
 
Date1 ____________________        Date2 ____________________ 
 
 Time1 Time2  Time1 Time2 
Creatinine    Potassium   
Phosphate   Albumin   
Hemoglobin   Kt/V    
 
 
































Appendix G: Nonadherence Measures 
QUESTIONS ABOUT PD EXCHANGES 












Some people forget to perform 
PD exchanges/ session. Overall, 












Some say that they decide to skip 
one of their PD exchanges/session 
or adjust the length to suit their 
own needs.  Overall, how often do 











During the last 4 weeks how many time have skipped/missed one of your PD 
sessions/exchanges? _____________________________________________________ 
During the past 4 weeks how many times have you prolonged/shorten your PD session 
by 10 minutes ?____________________________________________________ 
 
QUESTIONS ABOUT TAKING YOUR MEDICINES 












Some people forget to take their 
medicines.  Overall, how often 











Some people decide to miss out a 
dose of their medication or adjust 
it to suit their own needs. Overall, 














QUESTIONS ABOUT DIET 
Have you been asked to follow a 
diet? 1 YES 
2 
NO 
(ignore questions below) 












Some people forget to follow 
dietary recommendations.  
Overall, how often does this 











Some people decide to adjust their 
diet to suit their own needs. 
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